reverses diabetes type 2

🔥+ reverses diabetes type 2 08 Jul 2020 In Type II diabetes, the body stops responding to insulin. Both cases result in high blood sugar levels, which can cause problems with your eyes, nerves, kidneys, ...

reverses diabetes type 2 Studies dating back nearly a century noted a striking finding: If you take young, healthy people and split them up into two groups—half on a ...

best fruit to dehydrate for diabetes type 2
From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Management of diabetes

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentration of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance. The pancreas of a person with type 2 diabetes may be producing normal or even abnormally large amounts of insulin. Other forms of diabetes mellitus, such as the various forms of maturity onset diabetes of the young, may represent some combination of insufficient insulin production and insulin resistance. Some degree of insulin resistance may also be present in a person with type 1 diabetes.

The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Other goals of diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment.

Contents

Overview[edit]

Goals[edit]

The treatment goals are related to effective control of blood glucose, blood pressure and lipids, to minimize the risk of long-term consequences associated with diabetes. They are suggested in clinical practice guidelines released by various national and international diabetes agencies.

The targets are:

  • HbA1c of less than 6% or 7.0% if they are achievable without significant hypoglycemia[1][2]
  • Preprandial blood glucose: 3.9 to 7.2 mmol/L (70 to 130 mg/dl)[1]
  • 2-hour postprandial blood glucose: <10 mmol/L (<180 mg/dl)[1]

Goals should be individualized based on:[1]

In older patients, clinical practice guidelines by the American Geriatrics Society states "".[3] In older patients, clinical practice guidelines by the American Geriatrics Society states "".[3]

Issues[edit]

The primary issue requiring management is that of the glucose cycle. In this, glucose in the bloodstream is made available to cells in the body; a process dependent upon the twin cycles of glucose entering the bloodstream, and insulin allowing appropriate uptake into the body cells. Both aspects can require management. Another issue that ties along with the glucose cycle is getting a balanced amount of the glucose to the major organs so they are not affected negatively.

Complexities[edit]

Daily glucose and insulin cycle

The main complexities stem from the nature of the feedback loop of the glucose cycle, which is sought to be regulated:

  • The glucose cycle is a system which is affected by two factors: entry of glucose into the bloodstream and also blood levels of insulin to control its transport out of the bloodstream
  • As a system, it is sensitive to diet and exercise
  • It is affected by the need for user anticipation due to the complicating effects of time delays between any activity and the respective impact on the glucose system
  • Management is highly intrusive, and compliance is an issue, since it relies upon user lifestyle change and often upon regular sampling and measuring of blood glucose levels, multiple times a day in many cases
  • It changes as people grow and develop
  • It is highly individual

As diabetes is a prime risk factor for cardiovascular disease, controlling other risk factors which may give rise to secondary conditions, as well as the diabetes itself, is one of the facets of diabetes management. Checking cholesterol, LDL, HDL and triglyceride levels may indicate hyperlipoproteinemia, which may warrant treatment with hypolipidemic drugs. Checking the blood pressure and keeping it within strict limits (using diet and antihypertensive treatment) protects against the retinal, renal and cardiovascular complications of diabetes. Regular follow-up by a podiatrist or other foot health specialists is encouraged to prevent the development of diabetic foot. Annual eye exams are suggested to monitor for progression of diabetic retinopathy.

reverses diabetes type 2 mellitus nature journal (🔴 questionnaire) | reverses diabetes type 2 recommendationshow to reverses diabetes type 2 for Early advancements[edit]

Late in the 19th century, sugar in the urine (glycosuria) was associated with diabetes. Various doctors studied the connection. Frederick Madison Allen studied diabetes in 1909–12, then published a large volume, Studies Concerning Glycosuria and Diabetes, (Boston, 1913). He invented a fasting treatment for diabetes called the Allen treatment for diabetes. His diet was an early attempt at managing diabetes.

Blood sugar level[edit]

Blood sugar level is measured by means of a glucose meter, with the result either in mg/dL (milligrams per deciliter in the US) or mmol/L (millimoles per litre in Canada and Eastern Europe) of blood. The average normal person has an average fasting glucose level of 4.5 mmol/L (81 mg/dL), with a lows of down to 2.5 and up to 5.4 mmol/L (65 to 98 mg/dL).[4] Blood sugar level is measured by means of a glucose meter, with the result either in mg/dL (milligrams per deciliter in the US) or mmol/L (millimoles per litre in Canada and Eastern Europe) of blood. The average normal person has an average fasting glucose level of 4.5 mmol/L (81 mg/dL), with a lows of down to 2.5 and up to 5.4 mmol/L (65 to 98 mg/dL).[4]

Optimal management of diabetes involves patients measuring and recording their own blood glucose levels. By keeping a diary of their own blood glucose measurements and noting the effect of food and exercise, patients can modify their lifestyle to better control their diabetes. For patients on insulin, patient involvement is important in achieving effective dosing and timing.

Hypo and hyperglycemia[edit]

Levels which are significantly above or below this range are problematic and can in some cases be dangerous. A level of <3.8 mmol/L (<70 mg/dL) is usually described as a hypoglycemic attack (low blood sugar). Most diabetics know when they are going to "" and usually are able to eat some food or drink something sweet to raise levels. A patient who is hyperglycemic (high glucose) can also become temporarily hypoglycemic, under certain conditions (e.g. not eating regularly, or after strenuous exercise, followed by fatigue). Intensive efforts to achieve blood sugar levels close to normal have been shown to triple the risk of the most severe form of hypoglycemia, in which the patient requires assistance from by-standers in order to treat the episode.[5] In the United States, there were annually 48,500 hospitalizations for diabetic hypoglycemia and 13,100 for diabetic hypoglycemia resulting in coma in the period 1989 to 1991, before intensive blood sugar control was as widely recommended as today.[6] One study found that hospital admissions for diabetic hypoglycemia increased by 50% from 1990–1993 to 1997–2000, as strict blood sugar control efforts became more common.[7] Among intensively controlled type 1 diabetics, 55% of episodes of severe hypoglycemia occur during sleep, and 6% of all deaths in diabetics under the age of 40 are from nocturnal hypoglycemia in the so-called '' while National Institute of Health statistics show that 2% to 4% of all deaths in diabetics are from hypoglycemia.[8] In children and adolescents following intensive blood sugar control, 21% of hypoglycemic episodes occurred without explanation.[9] In addition to the deaths caused by diabetic hypoglycemia, periods of severe low blood sugar can also cause permanent brain damage.[10] Although diabetic nerve disease is usually associated with hyperglycemia, hypoglycemia as well can initiate or worsen neuropathy in diabetics intensively struggling to reduce their hyperglycemia.[11]

Levels greater than 13–15 mmol/L (230–270 mg/dL) are considered high, and should be monitored closely to ensure that they reduce rather than continue to remain high. The patient is advised to seek urgent medical attention as soon as possible if blood sugar levels continue to rise after 2–3 tests. High blood sugar levels are known as hyperglycemia, which is not as easy to detect as hypoglycemia and usually happens over a period of days rather than hours or minutes. If left untreated, this can result in diabetic coma and death.

A blood glucose test strip for an older style (i.e., optical color sensing) monitoring system

Prolonged and elevated levels of glucose in the blood, which is left unchecked and untreated, will, over time, result in serious diabetic complications in those susceptible and sometimes even death. There is currently no way of testing for susceptibility to complications. Diabetics are therefore recommended to check their blood sugar levels either daily or every few days. There is also diabetes management software available from blood testing manufacturers which can display results and trends over time. Type 1 diabetics normally check more often, due to insulin therapy.

A history of blood sugar level results is especially useful for the diabetic to present to their doctor or physician in the monitoring and control of the disease. Failure to maintain a strict regimen of testing can accelerate symptoms of the condition, and it is therefore imperative that any diabetic patient strictly monitor their glucose levels regularly.

Glycemic control[edit][edit]

Glycemic control is a medical term referring to the typical levels of blood sugar (glucose) in a person with diabetes mellitus. Much evidence suggests that many of the long-term complications of diabetes, especially the microvascular complications, result from many years of hyperglycemia (elevated levels of glucose in the blood). Good glycemic control, in the sense of a "" for treatment, has become an important goal of diabetes care, although recent research suggests that the complications of diabetes may be caused by genetic factors[12] or, in type 1 diabetics, by the continuing effects of the autoimmune disease which first caused the pancreas to lose its insulin-producing ability.[13]

Because blood sugar levels fluctuate throughout the day and glucose records are imperfect indicators of these changes, the percentage of hemoglobin which is glycosylated is used as a proxy measure of long-term glycemic control in research trials and clinical care of people with diabetes. This test, the hemoglobin A1c or glycosylated hemoglobin reflects average glucoses over the preceding 2–3 months. In nondiabetic persons with normal glucose metabolism the glycosylated hemoglobin is usually 4–6% by the most common methods (normal ranges may vary by method).

"" would mean that glucose levels were always normal (70–130 mg/dl, or 3.9–7.2 mmol/L) and indistinguishable from a person without diabetes. In reality, because of the imperfections of treatment measures, even "" describes blood glucose levels that average somewhat higher than normal much of the time. In addition, one survey of type 2 diabetics found that they rated the harm to their quality of life from intensive interventions to control their blood sugar to be just as severe as the harm resulting from intermediate levels of diabetic complications.[14]

reverses diabetes type 2 ketones in urine (☑ natural home remedies for) | reverses diabetes type 2 young age complicationshow to reverses diabetes type 2 for In the 1990s the American Diabetes Association conducted a publicity campaign to persuade patients and physicians to strive for average glucose and hemoglobin A1c values below 200 mg/dl (11 mmol/l) and 8%. Currently many patients and physicians attempt to do better than that.

As of 2015 the guidelines called for an HbA1c of around 7% or a fasting glucose of less than 7.2 mmol/L (130 mg/dL); however these goals may be changed after professional clinical consultation, taking into account particular risks of hypoglycemia and the 1 last update 08 Jul 2020 life expectancy.[15][16] Despite guidelines recommending that intensive blood sugar control be based on balancing immediate harms and long-term benefits, many people – for example people with a life expectancy of less than nine years – who will not benefit are over-treated and do not experience clinically meaningful benefits.[17] As of 2015 the guidelines called for an HbA1c of around 7% or a fasting glucose of less than 7.2 mmol/L (130 mg/dL); however these goals may be changed after professional clinical consultation, taking into account particular risks of hypoglycemia and life expectancy.[15][16] Despite guidelines recommending that intensive blood sugar control be based on balancing immediate harms and long-term benefits, many people – for example people with a life expectancy of less than nine years – who will not benefit are over-treated and do not experience clinically meaningful benefits.[17]

reverses diabetes type 2 oral medications (⭐️ intervention) | reverses diabetes type 2 odorhow to reverses diabetes type 2 for Poor glycemic control refers to persistently elevated blood glucose and glycosylated hemoglobin levels, which may range from 200–500 mg/dl (11–28 mmol/L) and 9–15% or higher over months and years before severe complications occur. Meta-analysis of large studies done on the effects of tight vs. conventional, or more relaxed, glycemic control in type 2 diabetics have failed to demonstrate a difference in all-cause cardiovascular death, non-fatal stroke, or limb amputation, but decreased the risk of nonfatal heart attack by 15%. Additionally, tight glucose control decreased the risk of progression of retinopathy and nephropathy, and decreased the incidence peripheral neuropathy, but increased the risk of hypoglycemia 2.4 times.[18]

Monitoring[edit]

A modern portable blood glucose meter (OneTouch Ultra), displaying a reading of 5.4 mmol/L (98 mg/dL).

Relying on their own perceptions of symptoms of hyperglycemia or hypoglycemia is usually unsatisfactory as mild to moderate hyperglycemia causes no obvious symptoms in nearly all patients. Other considerations include the fact that, while food takes several hours to be digested and absorbed, insulin administration can have glucose lowering effects for as little as 2 hours or 24 hours or more (depending on the nature of the insulin preparation used and individual patient reaction). In addition, the onset and duration of the effects of oral hypoglycemic agents vary from type to type and from patient to patient.

Personal (home) glucose monitoringreverses diabetes type 2 episode (⭐️ pills) | reverses diabetes type 2 treatments lexingtonhow to reverses diabetes type 2 for [edit]

Control and outcomes of both types 1 and 2 diabetes may be improved by patients using home glucose meters to regularly measure their glucose levels.[citation needed] Glucose monitoring is both expensive (largely due to the cost of the consumable test strips) and requires significant commitment on the part of the patient. Lifestyle adjustments are generally made by the patients themselves following training by a clinician.

Regular blood testing, especially in type 1 diabetics, is helpful to keep adequate control of glucose levels and to reduce the chance of long term side effects of the disease. There are many (at least 20+) different types of blood monitoring devices available on the market today; not every meter suits all patients and it is a specific matter of choice for the patient, in consultation with a physician or other experienced professional, to find a meter that they personally find comfortable to use. The principle of the devices is virtually the same: a small blood sample is collected and measured. In one type of meter, the electrochemical, a small blood sample is produced by the patient using a lancet (a sterile pointed needle). The blood droplet is usually collected at the bottom of a test strip, while the other end is inserted in the glucose meter. This test strip contains various chemicals so that when the blood is applied, a small electrical charge is created between two contacts. This charge will vary depending on the glucose levels within the blood. In older glucose meters, the drop of blood is placed on top of a strip. A chemical reaction occurs and the strip changes color. The meter then measures the color of the strip optically.

Self-testing is clearly important in type I diabetes where the use of insulin therapy risks episodes of hypoglycemia and home-testing allows for adjustment of dosage on each administration.[19] Its benefit in type 2 diabetes has been more controversial, but recent studies[20] have resulted in guidance[21] that self-monitoring does not improve blood glucose or quality of life.

Benefits of control and reduced hospital admission have been reported.[22] However, patients on oral medication who do not self-adjust their drug dosage will miss many of the benefits of self-testing, and so it is questionable in this group. This is particularly so for patients taking monotherapy with metformin who are not at risk of hypoglycaemia. Regular 6 monthly laboratory testing of HbA1c (glycated haemoglobin) provides some assurance of long-term effective control and allows the adjustment of the patient''s blood sugar levels to rise and other foods as safe foods- that do not make a person''s blood glucose level and adjust insulin infusion appropriately. New advances in technology have overcome much of this problem. Small, portable insulin infusion pumps are available from several manufacturers. They allow a continuous infusion of small amounts of insulin to be delivered through the skin around the clock, plus the ability to give bolus doses when a person eats or has elevated blood glucose levels. This is very similar to how the pancreas works, but these pumps lack the 1 last update 08 Jul 2020 a continuous "" mechanism. Thus, the user is still at risk of giving too much or too little insulin unless blood glucose measurements are made. Benefits of control and reduced hospital admission have been reported.[22] However, patients on oral medication who do not self-adjust their drug dosage will miss many of the benefits of self-testing, and so it is questionable in this group. This is particularly so for patients taking monotherapy with metformin who are not at risk of hypoglycaemia. Regular 6 monthly laboratory testing of HbA1c (glycated haemoglobin) provides some assurance of long-term effective control and allows the adjustment of the patient''s blood sugar levels to rise and other foods as safe foods- that do not make a person''s blood glucose level and adjust insulin infusion appropriately. New advances in technology have overcome much of this problem. Small, portable insulin infusion pumps are available from several manufacturers. They allow a continuous infusion of small amounts of insulin to be delivered through the skin around the clock, plus the ability to give bolus doses when a person eats or has elevated blood glucose levels. This is very similar to how the pancreas works, but these pumps lack a continuous "" mechanism. Thus, the user is still at risk of giving too much or too little insulin unless blood glucose measurements are made.

A further danger of insulin treatment is that while diabetic microangiopathy is usually explained as the result of hyperglycemia, studies in rats indicate that the higher than normal level of insulin diabetics inject to control their hyperglycemia may itself promote small blood vessel disease.[11] While there is no clear evidence that controlling hyperglycemia reduces diabetic macrovascular and cardiovascular disease, there are indications that intensive efforts to normalize blood glucose levels may worsen cardiovascular and cause diabetic mortality.[36]

Driving[edit]

Paramedics in Southern California attend a diabetic man who lost effective control of his vehicle due to low blood sugar (hypoglycemia) and drove it over the curb and into the water main and backflow valve in front of this industrial building. He was not injured, but required emergency intravenous glucose.

Studies conducted in the United States[37] and Europe[38] showed that drivers with type 1 diabetes had twice as many collisions as their non-diabetic spouses, demonstrating the increased risk of driving collisions in the type 1 diabetes population. Diabetes can compromise driving safety in several ways. First, long-term complications of diabetes can interfere with the safe operation of a vehicle. For example, diabetic retinopathy (loss of peripheral vision or visual acuity), or peripheral neuropathy (loss of feeling in the feet) can impair a driver’s ability to read street signs, control the speed of the vehicle, apply appropriate pressure to the brakes, etc.

Second, hypoglycemia can affect a person’s thinking process, coordination, and state of consciousness.[39][40] This disruption in brain functioning is called neuroglycopenia. Studies have demonstrated that the effects of neuroglycopenia impair driving ability.[39][41] A study involving people with type 1 diabetes found that individuals reporting two or more hypoglycemia-related driving mishaps differ physiologically and behaviorally from their counterparts who report no such mishaps.[42] For example, during hypoglycemia, drivers who had two or more mishaps reported fewer warning symptoms, their driving was more impaired, and their body released less epinephrine (a hormone that helps raise BG). Additionally, individuals with a history of hypoglycemia-related driving mishaps appear to use sugar at a faster rate[43] and are relatively slower at processing information.[44] These findings indicate that although anyone with type 1 diabetes may be at some risk of experiencing disruptive hypoglycemia while driving, there is a subgroup of type 1 drivers who are more vulnerable to such events.

Given the above research findings, it is recommended that drivers with type 1 diabetes with a history of driving mishaps should never drive when their BG is less than 70 mg/dl (3.9 mmol/l). Instead, these drivers are advised to treat hypoglycemia and delay driving until their BG is above 90 mg/dl (5 mmol/l).[42] Such drivers should also learn as much as possible about what causes their hypoglycemia, and use this information to avoid future hypoglycemia while driving.

reverses diabetes type 2 episode (⭐️ neuropathy treatment) | reverses diabetes type 2 kidshow to reverses diabetes type 2 for Studies funded by the National Institutes of Health (NIH) have demonstrated that face-to-face training programs designed to help individuals with type 1 diabetes better anticipate, detect, and prevent extreme BG can reduce the occurrence of future hypoglycemia-related driving mishaps.[45][46][47] An internet-version of this training has also been shown to have significant beneficial results.[48] Additional NIH funded research to develop internet interventions specifically to help improve driving safety in drivers with type 1 diabetes is currently underway.[49]

Exenatidereverses diabetes type 2 physiology (👍 reddit) | reverses diabetes type 2 on insulinhow to reverses diabetes type 2 for [edit]

The U.S. Food and Drug Administration (FDA) has approved a treatment called Exenatide, based on the saliva of a Gila monster, to control blood sugar in patients with type 2 diabetes.

reverses diabetes type 2 mellitus 10 code (☑ long term effects) | reverses diabetes type 2 factshow to reverses diabetes type 2 for Other regimens the 1 last update 08 Jul 2020 [[edit]

Artificial Intelligence researcher Dr. Cynthia Marling, of the Ohio University Russ College of Engineering and Technology, in collaboration with the Appalachian Rural Health Institute Diabetes Center, is developing a case based reasoning system to aid in diabetes management. The goal of the project is to provide automated intelligent decision support to diabetes patients and their professional care providers by interpreting the ever-increasing quantities of data provided by current diabetes management technology and translating it into better care without time consuming manual effort on the part of an endocrinologist or diabetologist.[citation needed] This type of Artificial Intelligence-based treatment shows some promise with initial testing of a prototype system producing best practice treatment advice which anaylizing physicians deemed to have some degree of benefit over 70% of the time and advice of neutral benefit another nearly 25% of the time.[50]

Use of a "" is becoming an increasingly popular way to manage diabetes. A Diabetes Coach is usually a Certified diabetes educator (CDE) who is trained to help people in all aspects of caring for their diabetes. The CDE can advise the patient on diet, medications, proper use of insulin injections and pumps, exercise, and other ways to manage diabetes while living a healthy and active lifestyle. CDEs can be found locally or by contacting a company which provides personalized diabetes care using CDEs. Diabetes Coaches can speak to a patient on a pay-per-call basis or via a monthly plan.

Dental care[edit]

High blood glucose in diabetic people is a risk factor for developing gum and tooth problems, especially in post-puberty and aging individuals. Diabetic patients have greater chances of developing oral health problems such as tooth decay, salivary gland dysfunction, fungal infections, inflammatory skin disease, periodontal disease or taste impairment and thrush of the mouth.[51] The oral problems in persons suffering from diabetes can be prevented with a good control of the blood sugar levels, regular check-ups and a very good oral hygiene. By maintaining a good oral status, diabetic persons prevent losing their teeth as a result of various periodontal conditions.

Diabetic persons must increase their awareness about oral infections as they have a double impact on health. Firstly, people with diabetes are more likely to develop periodontal disease, which causes increased blood sugar levels, often leading to diabetes complications. Severe periodontal disease can increase blood sugar, contributing to increased periods of time when the body functions with a high blood sugar. This puts diabetics at increased risk for diabetic complications.[52]

The first symptoms of gum and tooth infection in diabetic persons are decreased salivary flow and burning mouth or tongue. Also, patients may experience signs like dry mouth, which increases the incidence of decay. Poorly controlled diabetes usually leads to gum recession, since plaque creates more harmful proteins in the gums.

Tooth decay and cavities are some of the first oral problems that individuals with diabetes are at risk for. Increased blood sugar levels translate into greater sugars and acids that attack the teeth and lead to gum diseases. Gingivitis can also occur as a result of increased blood sugar levels along with an inappropriate oral hygiene. Periodontitis is an oral disease caused by untreated gingivitis and which destroys the soft tissue and bone that support the teeth. This disease may cause the gums to pull away from the teeth which may eventually loosen and fall out. Diabetic people tend to experience more severe periodontitis because diabetes lowers the ability to resist infection[53] and also slows healing. At the same time, an oral infection such as periodontitis can make diabetes more for 1 last update 08 Jul 2020 difficult to control because it causes the blood sugar levels to rise.[54] Tooth decay and cavities are some of the first oral problems that individuals with diabetes are at risk for. Increased blood sugar levels translate into greater sugars and acids that attack the teeth and lead to gum diseases. Gingivitis can also occur as a result of increased blood sugar levels along with an inappropriate oral hygiene. Periodontitis is an oral disease caused by untreated gingivitis and which destroys the soft tissue and bone that support the teeth. This disease may cause the gums to pull away from the teeth which may eventually loosen and fall out. Diabetic people tend to experience more severe periodontitis because diabetes lowers the ability to resist infection[53] and also slows healing. At the same time, an oral infection such as periodontitis can make diabetes more difficult to control because it causes the blood sugar levels to rise.[54]

reverses diabetes type 2 in skinny people (👍 fasting blood sugar goal) | reverses diabetes type 2 high blood sugar symptomshow to reverses diabetes type 2 for To prevent further diabetic complications as well as serious oral problems, diabetic persons must keep their blood sugar levels under control and have a proper oral hygiene. A study in the Journal of Periodontology found that poorly controlled type 2 diabetic patients are more likely to develop periodontal disease than well-controlled diabetics are.[52] At the same time, diabetic patients are recommended to have regular checkups with a dental care provider at least once in three to four months. Diabetics who receive good dental care and have good insulin control typically have a better chance at avoiding gum disease to help prevent tooth loss.[55]

Dental care is therefore even more important for diabetic patients than for healthy individuals. Maintaining the teeth and gum for 1 last update 08 Jul 2020 healthy is done by taking some preventing measures such as regular appointments at a dentist and a very good oral hygiene. Also, oral health problems can be avoided by closely monitoring the blood sugar levels. Patients who keep better under control their blood sugar levels and diabetes are less likely to develop oral health problems when compared to diabetic patients who control their disease moderately or poorly. Dental care is therefore even more important for diabetic patients than for healthy individuals. Maintaining the teeth and gum healthy is done by taking some preventing measures such as regular appointments at a dentist and a very good oral hygiene. Also, oral health problems can be avoided by closely monitoring the blood sugar levels. Patients who keep better under control their blood sugar levels and diabetes are less likely to develop oral health problems when compared to diabetic patients who control their disease moderately or poorly.

Poor oral hygiene is a great factor to take under consideration when it comes to oral problems and even more in people with diabetes. Diabetic people are advised to brush their teeth at least twice a day, and if possible, after all meals and snacks. However, brushing in the morning and at night is mandatory as well as flossing and using an anti-bacterial mouthwash. Individuals who suffer from diabetes are recommended to use toothpaste that contains fluoride as this has proved to be the most efficient in fighting oral infections and tooth decay. Flossing must be done at least once a day, as well because it is helpful in preventing oral problems by removing the plaque between the teeth, which is not removed when brushing.

reverses diabetes type 2 and covid-19 (☑ naturally) | reverses diabetes type 2 vegetarian diethow to reverses diabetes type 2 for Diabetic patients must get professional dental cleanings every six months. In cases when dental surgery is needed, it is necessary to take some special precautions such as adjusting diabetes medication or taking antibiotics to prevent infection. Looking for early signs of gum disease (redness, swelling, bleeding gums) and informing the dentist about them is also helpful in preventing further complications. Quitting smoking is recommended to avoid serious diabetes complications and oral diseases.

Diabetic persons are advised to make morning appointments to the dental care provider as during this time of the day the blood sugar levels tend to be better kept under control. Not least, individuals who suffer from diabetes must make sure both their physician and dental care provider are informed and aware of their condition, medical history and periodontal status.

reverses diabetes type 2 episode (⭐️ pumps system) | reverses diabetes type 2 natural historyhow to reverses diabetes type 2 for Medication nonadherence[edit]

Because many patients with diabetes have two or more comorbidities, they often require multiple medications. The prevalence of medication nonadherence is high among patients with chronic conditions, such as diabetes, and nonadherence is associated with public health issues and higher health care costs. One reason for nonadherence is the cost of medications. Being able to detect cost-related nonadherence is important for health care professionals, because this can lead to strategies to assist patients with problems paying for their medications. Some of these strategies are use of generic drugs or therapeutic alternatives, substituting a prescription drug with an over-the-counter medication, and pill-splitting. Interventions to improve adherence can achieve reductions in diabetes morbidity and mortality, as well as significant cost savings to the health care system.[56] Smartphone apps have been found to improve self-management and health outcomes in people with diabetes through functions such as specific reminder alarms,[57] while working with mental health professionals has also been found to help people with diabetes develop the skills to manage their medications and challenges of self-management effectively.[58]

Psychological mechanisms and adherencereverses diabetes type 2 uncontrolled icd 10 (🔥 nursing diagnosis) | reverses diabetes type 2 youthhow to reverses diabetes type 2 for [edit][edit]

As self-management of diabetes typically involves lifestyle modifications, adherence may pose a significant self-management burden on many individuals.[59] For example, individuals with diabetes may find themselves faced with the need to self-monitor their blood glucose levels, adhere to healthier diets and maintain exercise regimens regularly in order to maintain metabolic control and reduce the risk of developing cardiovascular problems. Barriers to adherence have been associated with key psychological mechanisms: knowledge of self-management, beliefs about the efficacy of treatment and self-efficacy/perceived control.[59] Such mechanisms are inter-related, as one''s perception of diabetes, or one''s emotions (e.g. motivation to change), which in turn, affects one''s confidence in their ability to engage in a behaviour to achieve a desired outcome).[60]

As diabetes management is affected by an individual''s overall quality of life.[65]

Research[edit]

See also: Fluorescent glucose biosensors

Type 1 the 1 last update 08 Jul 2020 diabetesType 1 diabetes[edit]

Diabetes type 1 is caused by the destruction of enough beta cells to produce symptoms; these cells, which are found in the Islets of Langerhans in the pancreas, produce and secrete insulin, the single hormone responsible for allowing glucose to enter from the blood into cells (in addition to the hormone amylin, another hormone required for glucose homeostasis). Hence, the phrase "" means ""/wiki/Endogenous""mw-redirect""Endogenous"" and cooperative operation with counterregulatory hormones.

This section deals only with approaches for curing the underlying condition of diabetes type 1, by enabling the body to endogenously, in vivo, produce insulin in response to the level of blood glucose. It does not cover other approaches, such as, for instance, closed-loop integrated glucometer/insulin pump products, which could potentially increase the quality-of-life for some who have diabetes type 1, and may by some be termed "".

Encapsulation approach[edit][edit]

The Bio-artificial pancreas: a cross section of bio-engineered tissue with encapsulated islet cells delivering endocrine hormones in response to glucose

reverses diabetes type 2 young age (👍 overview) | reverses diabetes type 2 pumps systemhow to reverses diabetes type 2 for A biological approach to the artificial pancreas is to implant bioengineered tissue containing islet cells, which would secrete the amounts of insulin, amylin and glucagon needed in response to sensed glucose.

When islet cells have been transplanted via the Edmonton protocol, insulin production (and glycemic control) was restored, but at the expense of continued immunosuppression drugs. Encapsulation of the islet cells in a protective coating has been developed to block the immune response to transplanted cells, which relieves the burden of immunosuppression and benefits the longevity of the transplant.[66]

reverses diabetes type 2 ribbon (🔴 killer) | reverses diabetes type 2 dinner recipeshow to reverses diabetes type 2 for Stem the 1 last update 08 Jul 2020 cellsStem cells[edit]

Research is being done at several locations in which islet cells are developed from stem cells.

Stem cell research has also been suggested as a potential avenue for a cure since it may permit regrowth of Islet cells which are genetically part of the treated individual, thus perhaps eliminating the need for immuno-suppressants.[48] This new method autologous nonmyeloablative hematopoietic stem cell transplantation was developed by a research team composed by Brazilian and American scientists (Dr. Julio Voltarelli, Dr. Carlos Eduardo Couri, Dr Richard Burt, and colleagues) and it was the first study to use stem cell therapy in human diabetes mellitus This was initially tested in mice and in 2007 there was the first publication of stem cell therapy to treat this form of diabetes.[67] Until 2009, there was 23 patients included and followed for a mean period of 29.8 months (ranging from 7 to 58 months). In the trial, severe immunosuppression with high doses of cyclophosphamide and anti-thymocyte globulin is used with the aim of "" the immunologic system""immunologic reset""cite_ref-68""reference""#cite_note-68""mw-headline""Gene_therapy""mw-editsection""mw-editsection-bracket""/w/index.php?title=Diabetes_management&action=edit&section=28""Edit section: Gene therapy""mw-editsection-bracket""thumb tright""thumbinner""width:222px;""/wiki/File:Gene_therapy.jpg""image""""//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Gene_therapy.jpg/220px-Gene_therapy.jpg""async""220""165""thumbimage""//upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Gene_therapy.jpg/330px-Gene_therapy.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3d/Gene_therapy.jpg/440px-Gene_therapy.jpg 2x""495""371""thumbcaption""magnify""/wiki/File:Gene_therapy.jpg""internal""Enlarge""/wiki/Gene_therapy""Gene therapy""/wiki/Viral_vector""Viral vector""/wiki/DNA""DNA""/wiki/Insulin""Insulin""/wiki/Gene_therapy""Gene therapy""cite_ref-69""reference""#cite_note-69""cite_ref-70""reference""#cite_note-70""cite_ref-71""reference""#cite_note-71""cite_ref-72""reference""#cite_note-72""mw-headline""Type_2_diabetes""mw-editsection""mw-editsection-bracket""/w/index.php?title=Diabetes_management&action=edit&section=29""Edit section: Type 2 diabetes""mw-editsection-bracket""/wiki/Saturated_fat""Saturated fat""/wiki/Sugar""Sugar""/wiki/Carbohydrate""Carbohydrate""/wiki/Weight_loss""Weight loss""cite_ref-Barnard_2007_73-0""reference""#cite_note-Barnard_2007-73""cite_ref-pmid19386029_74-0""reference""#cite_note-pmid19386029-74""cite_ref-Safren,_S._2014_65-1""reference""#cite_note-Safren,_S._2014-65""/wiki/Testosterone_replacement_therapy""mw-redirect""Testosterone replacement therapy""/wiki/Testosterone""Testosterone""/wiki/Insulin_resistance""Insulin resistance""cite_ref-pmid18772488_75-0""reference""#cite_note-pmid18772488-75""cite_ref-76""reference""#cite_note-76""noprint Inline-Template""white-space:nowrap;""/wiki/Wikipedia:Manual_of_Style/Dates_and_numbers#Chronological_items""Wikipedia:Manual of Style/Dates and numbers""The time period mentioned near this tag is ambiguous. (April 2011)""/wiki/Gastric_bypass_surgery""Gastric bypass surgery""cite_ref-pmid12409659_77-0""reference""#cite_note-pmid12409659-77""cite_ref-pmid17715409_78-0""reference""#cite_note-pmid17715409-78""cite_ref-pmid17386401_79-0""reference""#cite_note-pmid17386401-79""cite_ref-NS_80-0""reference""#cite_note-NS-80""/wiki/MODY""mw-redirect""MODY""cite_ref-81""reference""#cite_note-81""mw-headline""See_also""mw-editsection""mw-editsection-bracket""/w/index.php?title=Diabetes_management&action=edit&section=30""Edit section: See also""mw-editsection-bracket""div-col columns column-width""-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;""/wiki/Ambulatory_care_sensitive_conditions""mw-redirect""Ambulatory care sensitive conditions""/wiki/Diabetic_coma""Diabetic coma""/wiki/Diabetic_hypoglycemia""Diabetic hypoglycemia""/wiki/Diabetic_hypoglycemia_journal""mw-redirect""Diabetic hypoglycemia journal""/wiki/Glycemic_efficacy""Glycemic efficacy""/wiki/Latent_autoimmune_diabetes_of_adults""mw-redirect""Latent autoimmune diabetes of adults""mw-headline""References""mw-editsection""mw-editsection-bracket""/w/index.php?title=Diabetes_management&action=edit&section=31""Edit section: References""mw-editsection-bracket""reflist""list-style-type: decimal;""mw-references-wrap mw-references-columns""references""cite_note-ADA2019-1""mw-cite-backlink""#cite_ref-ADA2019_1-0""#cite_ref-ADA2019_1-1""#cite_ref-ADA2019_1-2""#cite_ref-ADA2019_1-3""reference-text""CITEREFAmerican_Diabetes_Association2019""citation journal""nofollow""external text""http://care.diabetesjournals.org/content/42/Supplement_1/S61""Standards of Medical Care in Diabetes 2019""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.2337%2Fdc19-S006""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/30559232""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Standards+of+Medical+Care+in+Diabetes+2019&rft.volume=37&rft.issue=suppl+1&rft.pages=6.4&rft.date=2019-01&rft_id=info%3Adoi%2F10.2337%2Fdc19-S006&rft_id=info%3Apmid%2F30559232&rft.au=American+Diabetes+Association&rft_id=http%3A%2F%2Fcare.diabetesjournals.org%2Fcontent%2F42%2FSupplement_1%2FS61&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""TemplateStyles:r951705291""\""""""''""//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png""//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg""//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png""//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg""//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png""//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg""//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png""//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg""cite_note-pmidpending-2""mw-cite-backlink""#cite_ref-pmidpending_2-0""reference-text""CITEREFQaseemVijanSnowCross2007""citation journal""Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.7326%2F0003-4819-147-6-200709180-00012""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17876024""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Internal+Medicine&rft.atitle=Glycemic+control+and+type+2+diabetes+mellitus%3A+the+optimal+hemoglobin+A1c+targets.+A+guidance+statement+from+the+American+College+of+Physicians&rft.volume=147&rft.issue=6&rft.pages=417-22&rft.date=2007-09&rft_id=info%3Adoi%2F10.7326%2F0003-4819-147-6-200709180-00012&rft_id=info%3Apmid%2F17876024&rft.aulast=Qaseem&rft.aufirst=A&rft.au=Vijan%2C+S&rft.au=Snow%2C+V&rft.au=Cross%2C+JT&rft.au=Weiss%2C+KB&rft.au=Owens%2C+DK&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-pmid12694461-3""mw-cite-backlink""#cite_ref-pmid12694461_3-0""reference-text""CITEREFBrownMangioneSalibaSarkisian2003""citation journal""nofollow""external text""https://semanticscholar.org/paper/b31336e3eda489953f1c50168663fb7360a1e03b""Guidelines for improving the care of the older person with diabetes mellitus""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1046%2Fj.1532-5415.51.5s.1.x""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/12694461""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=J+Am+Geriatr+Soc&rft.atitle=Guidelines+for+improving+the+care+of+the+older+person+with+diabetes+mellitus&rft.volume=51&rft.issue=5+Suppl+Guidelines&rft.pages=S265-80&rft.date=2003-05&rft_id=info%3Adoi%2F10.1046%2Fj.1532-5415.51.5s.1.x&rft_id=info%3Apmid%2F12694461&rft.aulast=Brown&rft.aufirst=AF&rft.au=Mangione%2C+CM&rft.au=Saliba%2C+D&rft.au=Sarkisian%2C+CA&rft.au=California+Healthcare+Foundation%2FAmerican+Geriatrics+Society+Panel+on+Improving+Care+for+Elders+with+Diabetes&rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2Fb31336e3eda489953f1c50168663fb7360a1e03b&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-4""mw-cite-backlink""#cite_ref-4""reference-text""CITEREFAroraBinjooReddyKaur2015""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC4606601""Determination of normal range for fasting salivary glucose in Type 1 diabetics""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.4103%2F2231-0762.165923""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/2231-0762""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC4606601""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/26539389""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+International+Society+of+Preventive+%26+Community+Dentistry&rft.atitle=Determination+of+normal+range+for+fasting+salivary+glucose+in+Type+1+diabetics&rft.volume=5&rft.issue=5&rft.pages=377-82&rft.date=2015-01-01&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4606601&rft.issn=2231-0762&rft_id=info%3Apmid%2F26539389&rft_id=info%3Adoi%2F10.4103%2F2231-0762.165923&rft.aulast=Arora&rft.aufirst=Karandeep+Singh&rft.au=Binjoo%2C+Nagesh&rft.au=Reddy%2C+G.+V.+Ramachandra&rft.au=Kaur%2C+Prabhpreet&rft.au=Modgil%2C+Richa&rft.au=Negi%2C+Lalit+Singh&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4606601&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-5""mw-cite-backlink""#cite_ref-5""reference-text""CITEREFBriscoe2006""citation journal""Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.2337%2Fdiaclin.24.3.115""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Diabetes&rft.atitle=Hypoglycemia+in+Type+1+and+Type+2+Diabetes%3A+Physiology%2C+Pathophysiology%2C+and+Management&rft.volume=24&rft.issue=3&rft.pages=115-21&rft.date=2006&rft_id=info%3Adoi%2F10.2337%2Fdiaclin.24.3.115&rft.aulast=Briscoe&rft.aufirst=V.+J.&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-6""mw-cite-backlink""#cite_ref-6""reference-text""CITEREFFishbeinPalumbo1995""citation book""Acute Metabolic Complications in Diabetes""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=Acute+Metabolic+Complications+in+Diabetes&rft.btitle=Diabetes+in+America&rft.place=Bethesda&rft.pages=283&rft.pub=National+Diabetes+Data+Group&rft.date=1995&rft.aulast=Fishbein&rft.aufirst=H.&rft.au=Palumbo%2C+P.&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-7""mw-cite-backlink""#cite_ref-7""reference-text""CITEREFAsuncionShaheenGanesanVelasques2007""citation journal""Increase in hypoglycemic admissions: California hospital discharge data""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17985510""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Ethnicity+%26+Disease&rft.atitle=Increase+in+hypoglycemic+admissions%3A+California+hospital+discharge+data&rft.volume=17&rft.issue=3&rft.pages=536-40&rft.date=2007&rft_id=info%3Apmid%2F17985510&rft.aulast=Asuncion&rft.aufirst=MM&rft.au=Shaheen%2C+M&rft.au=Ganesan%2C+K&rft.au=Velasques%2C+J&rft.au=Teklehaimanot%2C+S&rft.au=Pan%2C+D&rft.au=Norris%2C+K&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-8""mw-cite-backlink""#cite_ref-8""reference-text""CITEREFPerlmuterFlanaganShahSingh2008""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2551657""Glycemic Control and Hypoglycemia: Is the loser the winner?""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdc08-1441""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2551657""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/18820231""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Glycemic+Control+and+Hypoglycemia%3A+Is+the+loser+the+winner%3F&rft.volume=31&rft.issue=10&rft.pages=2072-76&rft.date=2008&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2551657&rft_id=info%3Apmid%2F18820231&rft_id=info%3Adoi%2F10.2337%2Fdc08-1441&rft.aulast=Perlmuter&rft.aufirst=LC&rft.au=Flanagan%2C+BP&rft.au=Shah%2C+PH&rft.au=Singh%2C+SP&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2551657&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-9""mw-cite-backlink""#cite_ref-9""reference-text""CITEREFTupolaRajantieMäenpää1998""citation journal""Severe hypoglycaemia in children and adolescents during multiple-dose insulin therapy""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1002%2F%28SICI%291096-9136%28199808%2915%3A8%3C695%3A%3AAID-DIA651%3E3.0.CO%3B2-C""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/9702475""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetic+Medicine&rft.atitle=Severe+hypoglycaemia+in+children+and+adolescents+during+multiple-dose+insulin+therapy&rft.volume=15&rft.issue=8&rft.pages=695-69&rft.date=1998&rft_id=info%3Adoi%2F10.1002%2F%28SICI%291096-9136%28199808%2915%3A8%3C695%3A%3AAID-DIA651%3E3.0.CO%3B2-C&rft_id=info%3Apmid%2F9702475&rft.aulast=Tupola&rft.aufirst=S&rft.au=Rajantie%2C+J&rft.au=M%C3%A4enp%C3%A4%C3%A4%2C+J&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-10""mw-cite-backlink""#cite_ref-10""reference-text""CITEREFFujiokaOkuchiHiramatsuSakaki1997""citation journal""Specific changes in human brain after hypoglycemic injury""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1161%2F01.STR.28.3.584""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/9056615""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Stroke%3A+A+Journal+of+Cerebral+Circulation&rft.atitle=Specific+changes+in+human+brain+after+hypoglycemic+injury&rft.volume=28&rft.issue=3&rft.pages=584-87&rft.date=1997&rft_id=info%3Adoi%2F10.1161%2F01.STR.28.3.584&rft_id=info%3Apmid%2F9056615&rft.aulast=Fujioka&rft.aufirst=M&rft.au=Okuchi%2C+K&rft.au=Hiramatsu%2C+KI&rft.au=Sakaki%2C+T&rft.au=Sakaguchi%2C+S&rft.au=Ishii%2C+Y&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-ReferenceA-11""mw-cite-backlink""#cite_ref-ReferenceA_11-0""#cite_ref-ReferenceA_11-1""reference-text""CITEREFSugimotoBabaSudaYasujima2003""citation journal""Peripheral neuropathy and microangiopathy in rats with insulinoma: association with chronic hyperinsulinemia""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1002%2Fdmrr.395""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/12951647""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes%2FMetabolism+Research+and+Reviews&rft.atitle=Peripheral+neuropathy+and+microangiopathy+in+rats+with+insulinoma%3A+association+with+chronic+hyperinsulinemia&rft.volume=19&rft.issue=5&rft.pages=392-400&rft.date=2003&rft_id=info%3Adoi%2F10.1002%2Fdmrr.395&rft_id=info%3Apmid%2F12951647&rft.aulast=Sugimoto&rft.aufirst=K&rft.au=Baba%2C+M&rft.au=Suda%2C+T&rft.au=Yasujima%2C+M&rft.au=Yagihashi%2C+S&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-12""mw-cite-backlink""#cite_ref-12""reference-text""CITEREFTarnowGroopHadjadjKazeem2008""citation journal""European rational approach for the genetics of diabetic complications – EURAGEDIC: patient populations and strategy""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.1093%2Fndt%2Fgfm501""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17704113""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Nephrology%2C+Dialysis%2C+Transplantation&rft.atitle=European+rational+approach+for+the+genetics+of+diabetic+complications+%E2%80%93+EURAGEDIC%3A+patient+populations+and+strategy&rft.volume=23&rft.issue=1&rft.pages=161-68&rft.date=2008&rft_id=info%3Adoi%2F10.1093%2Fndt%2Fgfm501&rft_id=info%3Apmid%2F17704113&rft.aulast=Tarnow&rft.aufirst=L&rft.au=Groop%2C+PH&rft.au=Hadjadj%2C+S&rft.au=Kazeem%2C+G&rft.au=Cambien%2C+F&rft.au=Marre%2C+M&rft.au=Forsblom%2C+C&rft.au=Parving%2C+HH&rft.au=Tr%C3%A9gou%C3%ABt%2C+D&rft.au=Thevard%2C+A.&rft.au=Farrall%2C+M.&rft.au=Gut%2C+I.&rft.au=Gauguier%2C+D.&rft.au=Cox%2C+R.&rft.au=Matsuda%2C+F.&rft.au=Lathrop%2C+M.&rft.au=Vionnet%2C+N.&rft.au=Euragedic%2C+Consortium&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-13""mw-cite-backlink""#cite_ref-13""reference-text""CITEREFAdams2008""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2693966""Autoimmune destruction of pericytes as the cause of diabetic retinopathy""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2147%2FOPTH.S2629""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2693966""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/19668719""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Clinical+Ophthalmology&rft.atitle=Autoimmune+destruction+of+pericytes+as+the+cause+of+diabetic+retinopathy&rft.volume=2&rft.issue=2&rft.pages=295-98&rft.date=2008&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2693966&rft_id=info%3Apmid%2F19668719&rft_id=info%3Adoi%2F10.2147%2FOPTH.S2629&rft.aulast=Adams&rft.aufirst=DD&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2693966&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-14""mw-cite-backlink""#cite_ref-14""reference-text""CITEREFHuangBrownEwigmanFoley2007""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2288662""Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdc07-0499""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2288662""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17623824""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Patient+Perceptions+of+Quality+of+Life+With+Diabetes-Related+Complications+and+Treatments&rft.volume=30&rft.issue=10&rft.pages=2478-83&rft.date=2007&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2288662&rft_id=info%3Apmid%2F17623824&rft_id=info%3Adoi%2F10.2337%2Fdc07-0499&rft.aulast=Huang&rft.aufirst=ES&rft.au=Brown%2C+SE&rft.au=Ewigman%2C+BG&rft.au=Foley%2C+EC&rft.au=Meltzer%2C+DO&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2288662&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-ADA2015-15""mw-cite-backlink""#cite_ref-ADA2015_15-0""reference-text""CITEREFInzucchiBergenstalBuseDiamant2015""citation journal""Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.1007%2Fs00125-014-3460-0""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/25583541""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetologia&rft.atitle=Management+of+hyperglycaemia+in+type+2+diabetes%2C+2015%3A+a+patient-centred+approach.+Update+to+a+Position+Statement+of+the+American+Diabetes+Association+and+the+European+Association+for+the+Study+of+Diabetes.&rft.volume=58&rft.issue=3&rft.pages=429-42&rft.date=2015-03&rft_id=info%3Adoi%2F10.1007%2Fs00125-014-3460-0&rft_id=info%3Apmid%2F25583541&rft.aulast=Inzucchi&rft.aufirst=SE&rft.au=Bergenstal%2C+RM&rft.au=Buse%2C+JB&rft.au=Diamant%2C+M&rft.au=Ferrannini%2C+E&rft.au=Nauck%2C+M&rft.au=Peters%2C+AL&rft.au=Tsapas%2C+A&rft.au=Wender%2C+R&rft.au=Matthews%2C+DR&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-ADA21015-16""mw-cite-backlink""#cite_ref-ADA21015_16-0""reference-text""citation journal""Standards of Medical Care in Diabetes: Summary of Revisions""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.2337%2Fdc15-S003""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/25537706""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Standards+of+Medical+Care+in+Diabetes%3A+Summary+of+Revisions&rft.volume=54&rft.issue=38&rft.pages=S4&rft.date=2015&rft_id=info%3Adoi%2F10.2337%2Fdc15-S003&rft_id=info%3Apmid%2F25537706&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-17""mw-cite-backlink""#cite_ref-17""reference-text""CITEREFMakamNguyen2017""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5502688""An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1161%2FCIRCULATIONAHA.116.022622""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5502688""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/28069712""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Circulation&rft.atitle=An+Evidence-Based+Medicine+Approach+to+Antihyperglycemic+Therapy+in+Diabetes+Mellitus+to+Overcome+Overtreatment.&rft.volume=135&rft.issue=2&rft.pages=180-95&rft.date=2017-01-10&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5502688&rft_id=info%3Apmid%2F28069712&rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.116.022622&rft.aulast=Makam&rft.aufirst=AN&rft.au=Nguyen%2C+OK&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5502688&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-18""mw-cite-backlink""#cite_ref-18""reference-text""CITEREFBuehler_AMCavalcanti_ABBerwanger_O2013""citation journal""Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1111%2Fj.1755-5922.2011.00308.x""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/22212499""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Cardiovasc+Ther&rft.atitle=Effect+of+tight+blood+glucose+control+versus+conventional+control+in+patients+with+type+2+diabetes+mellitus%3A+a+systematic+review+with+meta-analysis+of+randomized+controlled+trials&rft.volume=31&rft.issue=3&rft.pages=147-60&rft.date=2013-06&rft_id=info%3Adoi%2F10.1111%2Fj.1755-5922.2011.00308.x&rft_id=info%3Apmid%2F22212499&rft.au=Buehler+AM&rft.au=Cavalcanti+AB&rft.au=Berwanger+O&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-BMJ1999-Evans-19""mw-cite-backlink""#cite_ref-BMJ1999-Evans_19-0""reference-text""CITEREFEvans,_Josie_M_MNewton,_Ray_WRuta,_Danny_AMacDonald,_Thomas_M1999""citation journal""nofollow""external text""http://bmj.bmjjournals.com/cgi/content/full/319/7202/83""Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1136%2Fbmj.319.7202.83""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC28155""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/10398627""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Frequency+of+blood+glucose+monitoring+in+relation+to+glycaemic+control%3A+observational+study+with+diabetes+database&rft.volume=319&rft.issue=7202&rft.pages=83-86&rft.date=1999&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC28155&rft_id=info%3Apmid%2F10398627&rft_id=info%3Adoi%2F10.1136%2Fbmj.319.7202.83&rft.au=Evans%2C+Josie+M+M&rft.au=Newton%2C+Ray+W&rft.au=Ruta%2C+Danny+A&rft.au=MacDonald%2C+Thomas+M&rft.au=Stevenson%2C+Richard+J&rft.au=Morris%2C+Andrew+D&rft_id=http%3A%2F%2Fbmj.bmjjournals.com%2Fcgi%2Fcontent%2Ffull%2F319%2F7202%2F83&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-20""mw-cite-backlink""#cite_ref-20""reference-text""CITEREFYoungBuseWeaverVu2017""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5818811""Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1001%2Fjamainternmed.2017.1233""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/2168-6106""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5818811""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/28600913""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA+Internal+Medicine&rft.atitle=Glucose+Self-monitoring+in+Non%E2%80%93Insulin-Treated+Patients+With+Type+2+Diabetes+in+Primary+Care+Settings%3A+A+Randomized+Trial&rft.volume=177&rft.issue=7&rft.pages=920-929&rft.date=2017-07-01&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5818811&rft.issn=2168-6106&rft_id=info%3Apmid%2F28600913&rft_id=info%3Adoi%2F10.1001%2Fjamainternmed.2017.1233&rft.aulast=Young&rft.aufirst=Laura+A.&rft.au=Buse%2C+John+B.&rft.au=Weaver%2C+Mark+A.&rft.au=Vu%2C+Maihan+B.&rft.au=Mitchell%2C+C.+Madeline&rft.au=Blakeney%2C+Tamara&rft.au=Grimm%2C+Kimberlea&rft.au=Rees%2C+Jennifer&rft.au=Niblock%2C+Franklin&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5818811&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-21""mw-cite-backlink""#cite_ref-21""reference-text""CITEREFPerryMoeKorownykLindblad2019""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC6467664""Top studies relevant to primary care from 2018""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/0008-350X""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC6467664""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/30979756""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Canadian+Family+Physician&rft.atitle=Top+studies+relevant+to+primary+care+from+2018&rft.volume=65&rft.issue=4&rft.pages=260-263&rft.date=2019-04&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6467664&rft.issn=0008-350X&rft_id=info%3Apmid%2F30979756&rft.aulast=Perry&rft.aufirst=Danielle&rft.au=Moe%2C+Samantha&rft.au=Korownyk%2C+Christina&rft.au=Lindblad%2C+Adrienne+J.&rft.au=Kolber%2C+Michael+R.&rft.au=Thomas%2C+Betsy&rft.au=Ton%2C+Joey&rft.au=Garrison%2C+Scott&rft.au=Allan%2C+G.+Michael&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6467664&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-DiabetesResClinPract1999-Kibriya-22""mw-cite-backlink""#cite_ref-DiabetesResClinPract1999-Kibriya_22-0""reference-text""CITEREFKibriyaAliBanikKhan1999""citation journal""Home monitoring of blood glucose (HMBG) in Type-2 diabetes mellitus in a developing country""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1016%2FS0168-8227%2899%2900093-5""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/10624792""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Research+and+Clinical+Practice&rft.atitle=Home+monitoring+of+blood+glucose+%28HMBG%29+in+Type-2+diabetes+mellitus+in+a+developing+country&rft.volume=46&rft.issue=3&rft.pages=253-57&rft.date=1999&rft_id=info%3Adoi%2F10.1016%2FS0168-8227%2899%2900093-5&rft_id=info%3Apmid%2F10624792&rft.aulast=Kibriya&rft.aufirst=MG&rft.au=Ali%2C+L&rft.au=Banik%2C+NG&rft.au=Khan%2C+AK&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-AnnUnivMariaeCurie2004-Jaworska-23""mw-cite-backlink""#cite_ref-AnnUnivMariaeCurie2004-Jaworska_23-0""reference-text""CITEREFJaworskaDziemidokKulikRudnicka-Drozak2004""citation journal""Frequency of self-monitoring and its effect on metabolic control in patients with type 2 diabetes""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/16146003""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annales+Universitatis+Mariae+Curie-Sklodowska.+Sectio+D%3A+Medicina&rft.atitle=Frequency+of+self-monitoring+and+its+effect+on+metabolic+control+in+patients+with+type+2+diabetes&rft.volume=59&rft.issue=1&rft.pages=310-16&rft.date=2004&rft_id=info%3Apmid%2F16146003&rft.aulast=Jaworska&rft.aufirst=J&rft.au=Dziemidok%2C+P&rft.au=Kulik%2C+TB&rft.au=Rudnicka-Drozak%2C+E&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-BMJ2004-Roach-24""mw-cite-backlink""#cite_ref-BMJ2004-Roach_24-0""reference-text""CITEREFRoach2004""citation journal""Better systems, not guidelines, for glucose monitoring""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1136%2Fbmj.329.7479.E332""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/15591539""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=BMJ&rft.atitle=Better+systems%2C+not+guidelines%2C+for+glucose+monitoring&rft.volume=329&rft.issue=7479&rft.pages=E332&rft.date=2004&rft_id=info%3Adoi%2F10.1136%2Fbmj.329.7479.E332&rft_id=info%3Apmid%2F15591539&rft.aulast=Roach&rft.aufirst=P&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-25""mw-cite-backlink""#cite_ref-25""reference-text""CITEREFJeongKimIn2020""citation journal""Detecting usability problems in mobile applications on the basis of dissimilarity in user behavior""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1016%2Fj.ijhcs.2019.10.001""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Human-Computer+Studies&rft.atitle=Detecting+usability+problems+in+mobile+applications+on+the+basis+of+dissimilarity+in+user+behavior&rft.volume=139&rft.pages=102364&rft.date=2020-07&rft_id=info%3Adoi%2F10.1016%2Fj.ijhcs.2019.10.001&rft.aulast=Jeong&rft.aufirst=JongWook&rft.au=Kim%2C+NeungHoe&rft.au=In%2C+Hoh+Peter&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-26""mw-cite-backlink""#cite_ref-26""reference-text""CITEREFSarkarGourleyLylesTieu2016""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5130945""Usability of Commercially Available Mobile Applications for Diverse Patients""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1007%2Fs11606-016-3771-6""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/0884-8734""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5130945""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/27418347""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+General+Internal+Medicine&rft.atitle=Usability+of+Commercially+Available+Mobile+Applications+for+Diverse+Patients&rft.volume=31&rft.issue=12&rft.pages=1417-1426&rft.date=2016-12&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5130945&rft.issn=0884-8734&rft_id=info%3Apmid%2F27418347&rft_id=info%3Adoi%2F10.1007%2Fs11606-016-3771-6&rft.aulast=Sarkar&rft.aufirst=Urmimala&rft.au=Gourley%2C+Gato+I.&rft.au=Lyles%2C+Courtney+R.&rft.au=Tieu%2C+Lina&rft.au=Clarity%2C+Cassidy&rft.au=Newmark%2C+Lisa&rft.au=Singh%2C+Karandeep&rft.au=Bates%2C+David+W.&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5130945&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-27""mw-cite-backlink""#cite_ref-27""reference-text""CITEREFHoodWilsonCorsicaBradley2016""citation journal""What do we know about mobile applications for diabetes self-management? A review of reviews""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1007%2Fs10865-016-9765-3""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/0160-7715""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/27412774""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Behavioral+Medicine&rft.atitle=What+do+we+know+about+mobile+applications+for+diabetes+self-management%3F+A+review+of+reviews&rft.volume=39&rft.issue=6&rft.pages=981-994&rft.date=2016-12&rft.issn=0160-7715&rft_id=info%3Apmid%2F27412774&rft_id=info%3Adoi%2F10.1007%2Fs10865-016-9765-3&rft.aulast=Hood&rft.aufirst=Megan&rft.au=Wilson%2C+Rebecca&rft.au=Corsica%2C+Joyce&rft.au=Bradley%2C+Lauren&rft.au=Chirinos%2C+Diana&rft.au=Vivo%2C+Amanda&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-Fu_e11462-28""mw-cite-backlink""#cite_ref-Fu_e11462_28-0""reference-text""CITEREFFuAdamKonstanWolfson2019""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC6660121""Influence of Patient Characteristics and Psychological Needs on Diabetes Mobile App Usability in Adults With Type 1 or Type 2 Diabetes: Crossover Randomized Trial""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2196%2F11462""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/2371-4379""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC6660121""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/31038468""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JMIR+Diabetes&rft.atitle=Influence+of+Patient+Characteristics+and+Psychological+Needs+on+Diabetes+Mobile+App+Usability+in+Adults+With+Type+1+or+Type+2+Diabetes%3A+Crossover+Randomized+Trial&rft.volume=4&rft.issue=2&rft.pages=e11462&rft.date=2019-04-30&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6660121&rft.issn=2371-4379&rft_id=info%3Apmid%2F31038468&rft_id=info%3Adoi%2F10.2196%2F11462&rft.aulast=Fu&rft.aufirst=Helen+NC&rft.au=Adam%2C+Terrence+J&rft.au=Konstan%2C+Joseph+A&rft.au=Wolfson%2C+Julian+A&rft.au=Clancy%2C+Thomas+R&rft.au=Wyman%2C+Jean+F&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6660121&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-29""mw-cite-backlink""#cite_ref-29""reference-text""citation news""nofollow""external text""http://www.pulsetoday.co.uk/clinical/clinical-specialties/obesity-and-nutrition/government-set-to-double-nhs-diabetes-prevention-programme/20038490.article""Government set to double NHS diabetes prevention programme""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Government+set+to+double+NHS+diabetes+prevention+programme&rft.date=2019-04-02&rft_id=http%3A%2F%2Fwww.pulsetoday.co.uk%2Fclinical%2Fclinical-specialties%2Fobesity-and-nutrition%2Fgovernment-set-to-double-nhs-diabetes-prevention-programme%2F20038490.article&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-t1diet-30""mw-cite-backlink""#cite_ref-t1diet_30-0""reference-text""citation web""nofollow""external text""https://www.diabetes.org.uk/diabetes-the-basics/food-and-diabetes/i-have-type-1-diabetes""I have Type 1 diabetes - what can I eat?""/wiki/Diabetes_UK""Diabetes UK""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=I+have+Type+1+diabetes+-+what+can+I+eat%3F&rft.pub=Diabetes+UK&rft_id=https%3A%2F%2Fwww.diabetes.org.uk%2Fdiabetes-the-basics%2Ffood-and-diabetes%2Fi-have-type-1-diabetes&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-ups-31""mw-cite-backlink""#cite_ref-ups_31-0""#cite_ref-ups_31-1""#cite_ref-ups_31-2""reference-text""CITEREFSeckoldFisherde_BockKing2018""citation journal""The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1111%2Fdme.13845""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/30362180""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabet.+Med.&rft.atitle=The+ups+and+downs+of+low-carbohydrate+diets+in+the+management+of+Type+1+diabetes%3A+a+review+of+clinical+outcomes&rft.volume=36&rft.issue=3&rft.pages=326-334&rft.date=2018-10&rft_id=info%3Adoi%2F10.1111%2Fdme.13845&rft_id=info%3Apmid%2F30362180&rft.aulast=Seckold&rft.aufirst=R&rft.au=Fisher%2C+E&rft.au=de+Bock%2C+M&rft.au=King%2C+BR&rft.au=Smart%2C+CE&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-tuomilehto-32""mw-cite-backlink""#cite_ref-tuomilehto_32-0""reference-text""CITEREFTuomilehtoLindströmErikssonValle2001""citation journal""Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1056%2FNEJM200105033441801""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/11333990""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+England+Journal+of+Medicine&rft.atitle=Prevention+of+type+2+diabetes+mellitus+by+changes+in+lifestyle+among+subjects+with+impaired+glucose+tolerance&rft.volume=344&rft.issue=18&rft.pages=1343-50&rft.date=2001&rft_id=info%3Adoi%2F10.1056%2FNEJM200105033441801&rft_id=info%3Apmid%2F11333990&rft.aulast=Tuomilehto&rft.aufirst=J&rft.au=Lindstr%C3%B6m%2C+J&rft.au=Eriksson%2C+JG&rft.au=Valle%2C+TT&rft.au=H%C3%A4m%C3%A4l%C3%A4inen%2C+H&rft.au=Ilanne-Parikka%2C+P&rft.au=Kein%C3%A4nen-Kiukaanniemi%2C+S&rft.au=Laakso%2C+M&rft.au=Louheranta%2C+A&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-Oramed-33""mw-cite-backlink""#cite_ref-Oramed_33-0""reference-text""CITEREFOramed_Pharmaceuticals2014""citation web""nofollow""external text""http://thepaleodiet.co.za/insulin-pill-for-diabetics/""Making insulin delivery in capsule form a reality""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Making+insulin+delivery+in+capsule+form+a+reality&rft.date=2014-09-25&rft.au=Oramed+Pharmaceuticals&rft_id=http%3A%2F%2Fthepaleodiet.co.za%2Finsulin-pill-for-diabetics%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-AMN-34""mw-cite-backlink""#cite_ref-AMN_34-0""reference-text""CITEREFMealey2006""citation web""nofollow""external text""http://www.health.am/db/diabetes-management/""Diabetes Mellitus Management""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=unknown&rft.jtitle=Diabetes+Mellitus+and+Oral+Health&rft.atitle=Diabetes+Mellitus+Management&rft.date=2006&rft.aulast=Mealey&rft.aufirst=Brian+L.&rft_id=http%3A%2F%2Fwww.health.am%2Fdb%2Fdiabetes-management%2F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-alexander-35""mw-cite-backlink""#cite_ref-alexander_35-0""reference-text""CITEREFAlexanderSehgal_NLMoloney_RMStafford_RS2008""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2868588""National trends in treatment of type 2 diabetes mellitus, 1994–2007""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1001%2Farchinte.168.19.2088""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2868588""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/18955637""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Archives+of+Internal+Medicine&rft.atitle=National+trends+in+treatment+of+type+2+diabetes+mellitus%2C+1994%E2%80%932007&rft.volume=168&rft.issue=19&rft.pages=2088-94&rft.date=2008-10-27&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2868588&rft_id=info%3Apmid%2F18955637&rft_id=info%3Adoi%2F10.1001%2Farchinte.168.19.2088&rft.aulast=Alexander&rft.aufirst=G+Caleb&rft.au=Sehgal+NL&rft.au=Moloney+RM&rft.au=Stafford+RS&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2868588&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-36""mw-cite-backlink""#cite_ref-36""reference-text""CITEREFMudaliar2009""citation journal""Serum glucose control in diabetic patients with cardiovascular disease: should we be less aggressive?""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1007%2Fs11883-009-0058-y""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/19664383""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Current+Atherosclerosis+Reports&rft.atitle=Serum+glucose+control+in+diabetic+patients+with+cardiovascular+disease%3A+should+we+be+less+aggressive%3F&rft.volume=11&rft.issue=5&rft.pages=384-90&rft.date=2009&rft_id=info%3Adoi%2F10.1007%2Fs11883-009-0058-y&rft_id=info%3Apmid%2F19664383&rft.aulast=Mudaliar&rft.aufirst=S&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-37""mw-cite-backlink""#cite_ref-37""reference-text""cite_note-38""mw-cite-backlink""#cite_ref-38""reference-text""CITEREFCoxPenberthyZrebiecWeinger2003""citation journal""Diabetes and Driving Mishaps: Frequency and correlations from a multinational survey""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.2337%2Fdiacare.26.8.2329""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/12882857""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Diabetes+and+Driving+Mishaps%3A+Frequency+and+correlations+from+a+multinational+survey&rft.volume=26&rft.issue=8&rft.pages=2329-34&rft.date=2003&rft_id=info%3Adoi%2F10.2337%2Fdiacare.26.8.2329&rft_id=info%3Apmid%2F12882857&rft.aulast=Cox&rft.aufirst=DJ&rft.au=Penberthy%2C+JK&rft.au=Zrebiec%2C+J&rft.au=Weinger%2C+K&rft.au=Aikens%2C+JE&rft.au=Frier%2C+BM&rft.au=Stetson%2C+B&rft.au=DeGroot%2C+M&rft.au=Trief%2C+P&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-Cox-39""mw-cite-backlink""#cite_ref-Cox_39-0""#cite_ref-Cox_39-1""reference-text""CITEREFCoxGonder-FrederickClarke1993""citation journal""Driving decrements in type 1 diabetes during moderate hypoglycemia""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdiabetes.42.2.239""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/8425660""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes&rft.atitle=Driving+decrements+in+type+1+diabetes+during+moderate+hypoglycemia&rft.volume=42&rft.issue=2&rft.pages=239-43&rft.date=1993&rft_id=info%3Adoi%2F10.2337%2Fdiabetes.42.2.239&rft_id=info%3Apmid%2F8425660&rft.aulast=Cox&rft.aufirst=DJ&rft.au=Gonder-Frederick%2C+LA&rft.au=Clarke%2C+WL&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-40""mw-cite-backlink""#cite_ref-40""reference-text""CITEREFClarkeCoxGonder-FrederickKovatchev1999""citation journal""Hypoglycemia and the Decision to Drive a Motor Vehicle by Persons With Diabetes""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.1001%2Fjama.282.8.750""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/10463710""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA&rft.atitle=Hypoglycemia+and+the+Decision+to+Drive+a+Motor+Vehicle+by+Persons+With+Diabetes&rft.volume=282&rft.issue=8&rft.pages=750-54&rft.date=1999&rft_id=info%3Adoi%2F10.1001%2Fjama.282.8.750&rft_id=info%3Apmid%2F10463710&rft.aulast=Clarke&rft.aufirst=WL&rft.au=Cox%2C+DJ&rft.au=Gonder-Frederick%2C+LA&rft.au=Kovatchev%2C+B&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-41""mw-cite-backlink""#cite_ref-41""reference-text""CITEREFCoxGonder-FrederickKovatchevJulian2000""citation journal""Progressive hypoglycemia's impact on driving simulation performance""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.2337%2Fdiacare.23.2.163""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/10868825""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Progressive+hypoglycemia%27s+impact+on+driving+simulation+performance&rft.volume=23&rft.issue=2&rft.pages=163-70&rft.date=2000&rft_id=info%3Adoi%2F10.2337%2Fdiacare.23.2.163&rft_id=info%3Apmid%2F10868825&rft.aulast=Cox&rft.aufirst=D&rft.au=Gonder-Frederick%2C+LA&rft.au=Kovatchev%2C+BP&rft.au=Julian%2C+DM&rft.au=Clarke%2C+WL&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-Cox_a-42""mw-cite-backlink""#cite_ref-Cox_a_42-0""#cite_ref-Cox_a_42-1""reference-text""CITEREFCoxKovatchevAndersonClarke2010""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2963507""Type 1 diabetic drivers with and without a history of recurrent hypoglycemia-related driving mishaps: physiological and performance differences during euglycemia and the induction of hypoglycemia""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdc09-2130""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2963507""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/20699432""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Type+1+diabetic+drivers+with+and+without+a+history+of+recurrent+hypoglycemia-related+driving+mishaps%3A+physiological+and+performance+differences+during+euglycemia+and+the+induction+of+hypoglycemia&rft.volume=33&rft.issue=11&rft.pages=2430-35&rft.date=2010-11&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2963507&rft_id=info%3Apmid%2F20699432&rft_id=info%3Adoi%2F10.2337%2Fdc09-2130&rft.aulast=Cox&rft.aufirst=DJ&rft.au=Kovatchev%2C+BP&rft.au=Anderson%2C+SM&rft.au=Clarke%2C+WL&rft.au=Gonder-Frederick%2C+LA&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2963507&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-43""mw-cite-backlink""#cite_ref-43""reference-text""CITEREFCoxGonder-FrederickKovatchevClarke2002""citation journal""The metabolic demands of driving for drivers with type 1 diabetes mellitus""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1002%2Fdmrr.306""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/12397580""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes%2FMetabolism+Research+and+Review&rft.atitle=The+metabolic+demands+of+driving+for+drivers+with+type+1+diabetes+mellitus&rft.volume=18&rft.issue=5&rft.pages=381-85&rft.date=2002&rft_id=info%3Adoi%2F10.1002%2Fdmrr.306&rft_id=info%3Apmid%2F12397580&rft.aulast=Cox&rft.aufirst=DJ&rft.au=Gonder-Frederick%2C+LA&rft.au=Kovatchev%2C+BP&rft.au=Clarke%2C+WL&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-44""mw-cite-backlink""#cite_ref-44""reference-text""CITEREFCampbellGonder-FrederickBroshekKovatchev2010""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2993428""Neurocognitive differences between drivers with type 1 diabetes with and without a recent history of recurrent driving mishaps""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1016%2Fj.ijdm.2010.05.014""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2993428""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/21127720""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Diabetes&rft.atitle=Neurocognitive+differences+between+drivers+with+type+1+diabetes+with+and+without+a+recent+history+of+recurrent+driving+mishaps&rft.volume=2&rft.issue=2&rft.pages=73-77&rft.date=2010&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2993428&rft_id=info%3Apmid%2F21127720&rft_id=info%3Adoi%2F10.1016%2Fj.ijdm.2010.05.014&rft.aulast=Campbell&rft.aufirst=LK&rft.au=Gonder-Frederick%2C+LA&rft.au=Broshek%2C+DK&rft.au=Kovatchev%2C+BP&rft.au=Anderson%2C+S&rft.au=Clarke%2C+WL&rft.au=Cox%2C+DJ&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2993428&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-45""mw-cite-backlink""#cite_ref-45""reference-text""CITEREFCoxGonder-FrederickJulianClarke1994""citation journal""Long-term follow-up evaluation of blood glucose awareness training""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdiacare.17.1.1""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/8112183""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Long-term+follow-up+evaluation+of+blood+glucose+awareness+training&rft.volume=17&rft.issue=1&rft.pages=1-5&rft.date=1994&rft_id=info%3Adoi%2F10.2337%2Fdiacare.17.1.1&rft_id=info%3Apmid%2F8112183&rft.aulast=Cox&rft.aufirst=DJ&rft.au=Gonder-Frederick%2C+LA&rft.au=Julian%2C+D&rft.au=Clarke%2C+W&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-46""mw-cite-backlink""#cite_ref-46""reference-text""CITEREFCoxGonder-FrederickPolonskySchlundt2001""citation journal""Blood Glucose Awareness Training (BGAT-II): Long term benefits""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.2337%2Fdiacare.24.4.637""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/11315822""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Blood+Glucose+Awareness+Training+%28BGAT-II%29%3A+Long+term+benefits&rft.volume=24&rft.issue=4&rft.pages=637-42&rft.date=2001&rft_id=info%3Adoi%2F10.2337%2Fdiacare.24.4.637&rft_id=info%3Apmid%2F11315822&rft.aulast=Cox&rft.aufirst=DJ&rft.au=Gonder-Frederick%2C+LA&rft.au=Polonsky%2C+W&rft.au=Schlundt%2C+D&rft.au=Julian%2C+D&rft.au=Kovatchev%2C+B&rft.au=Clarke%2C+WL&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-47""mw-cite-backlink""#cite_ref-47""reference-text""CITEREFBroers_S.Cessie_S.van_Vliet_KPSpinhoven_P.2002""citation journal""Blood glucose awareness training in Dutch type 1 diabetes patients""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1046%2Fj.1464-5491.2002.00682.x""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/11874433""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabet.+Med.&rft.atitle=Blood+glucose+awareness+training+in+Dutch+type+1+diabetes+patients&rft.volume=19&rft.issue=2&rft.pages=157-61&rft.date=2002&rft_id=info%3Adoi%2F10.1046%2Fj.1464-5491.2002.00682.x&rft_id=info%3Apmid%2F11874433&rft.au=Broers+S.&rft.au=Cessie+S.&rft.au=van+Vliet+KP&rft.au=Spinhoven+P.&rft.au=der+Ven+NC&rft.au=Radder+JK&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-48""mw-cite-backlink""#cite_ref-48""reference-text""CITEREFCoxRitterbandMageeClarke2008""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2494647""Blood Glucose Awareness Training Delivered Over The Internet""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdc07-1956""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2494647""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/18477813""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Blood+Glucose+Awareness+Training+Delivered+Over+The+Internet&rft.volume=31&rft.issue=8&rft.pages=1527-28&rft.date=2008&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2494647&rft_id=info%3Apmid%2F18477813&rft_id=info%3Adoi%2F10.2337%2Fdc07-1956&rft.aulast=Cox&rft.aufirst=DJ&rft.au=Ritterband%2C+L&rft.au=Magee%2C+J&rft.au=Clarke%2C+W&rft.au=Gonder-Frederick%2C+L&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2494647&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-49""mw-cite-backlink""#cite_ref-49""reference-text""nofollow""external free""http://www.DiabetesDriving.com""cite_note-walker-50""mw-cite-backlink""#cite_ref-walker_50-0""reference-text""CITEREFWalker2007""citation web""nofollow""external text""http://etd.ohiolink.edu/send-pdf.cgi/Walker%20Donald.pdf?acc_num=ohiou1194562654""Similarity Determination and Case Retrieval in an Intelligent Decision Support System for Diabetes Management""cs1-format""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Similarity+Determination+and+Case+Retrieval+in+an+Intelligent+Decision+Support+System+for+Diabetes+Management&rft.date=2007-11&rft.aulast=Walker&rft.aufirst=Donald&rft_id=http%3A%2F%2Fetd.ohiolink.edu%2Fsend-pdf.cgi%2FWalker%2520Donald.pdf%3Facc_num%3Dohiou1194562654&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-51""mw-cite-backlink""#cite_ref-51""reference-text""citation web""nofollow""external text""http://www.dentalcarediabetes.com""Oral diabetes care""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Oral+diabetes+care&rft_id=http%3A%2F%2Fwww.dentalcarediabetes.com&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-Gum_Disease_and_Diabetes-52""mw-cite-backlink""#cite_ref-Gum_Disease_and_Diabetes_52-0""#cite_ref-Gum_Disease_and_Diabetes_52-1""reference-text""citation web""nofollow""external text""https://web.archive.org/web/20100612195938/http://perio.org/consumer/mbc.diabetes.htm""Gum Disease and Diabetes""nofollow""external text""http://www.perio.org/consumer/mbc.diabetes.htm""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Gum+Disease+and+Diabetes&rft_id=http%3A%2F%2Fwww.perio.org%2Fconsumer%2Fmbc.diabetes.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-53""mw-cite-backlink""#cite_ref-53""reference-text""CITEREFKoh_GCKWvan_der_Poll_TPeacock_SJ2011""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC3303037""The impact of diabetes on the pathogenesis of sepsis""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1007%2Fs10096-011-1337-4""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC3303037""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/21805196""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Eur+J+Clin+Microbiol+Infect+Dis&rft.atitle=The+impact+of+diabetes+on+the+pathogenesis+of+sepsis&rft.volume=31&rft.issue=4&rft.pages=379-88&rft.date=2011&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3303037&rft_id=info%3Apmid%2F21805196&rft_id=info%3Adoi%2F10.1007%2Fs10096-011-1337-4&rft.au=Koh+GCKW&rft.au=van+der+Poll+T&rft.au=Peacock+SJ&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3303037&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-54""mw-cite-backlink""#cite_ref-54""reference-text""citation web""nofollow""external text""http://www.mayoclinic.com/health/diabetes/DA00013/NSECTIONGROUP=2""Diabetes and Dental Care: Guide to a Healthy Mouth""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Diabetes+and+Dental+Care%3A+Guide+to+a+Healthy+Mouth&rft_id=http%3A%2F%2Fwww.mayoclinic.com%2Fhealth%2Fdiabetes%2FDA00013%2FNSECTIONGROUP%3D2&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-55""mw-cite-backlink""#cite_ref-55""reference-text""citation web""nofollow""external text""https://web.archive.org/web/20100424115557/http://www.dentalgentlecare.com/diabetes.htm""Diabetes and Oral Health""nofollow""external text""http://www.dentalgentlecare.com/diabetes.htm""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=unknown&rft.btitle=Diabetes+and+Oral+Health&rft_id=http%3A%2F%2Fwww.dentalgentlecare.com%2Fdiabetes.htm&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-56""mw-cite-backlink""#cite_ref-56""reference-text""CITEREFChan_M2010""citation journal""nofollow""external text""http://dbt.consultantlive.com/diabetes-management/content/article/1145628/1554670""Reducing cost-related medication nonadherence in patients with diabetes""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Drug+Benefit+Trends&rft.atitle=Reducing+cost-related+medication+nonadherence+in+patients+with+diabetes&rft.volume=22&rft.pages=67-71&rft.date=2010&rft.au=Chan+M&rft_id=http%3A%2F%2Fdbt.consultantlive.com%2Fdiabetes-management%2Fcontent%2Farticle%2F1145628%2F1554670&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-57""mw-cite-backlink""#cite_ref-57""reference-text""CITEREFCui,_M.Wu,_X.Mao,_J.Wang,_X.2016""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5115794""T2DM Self-Management via Smartphone Applications: A Systematic Review and Meta-Analysis""/wiki/Bibcode_(identifier)""mw-redirect""Bibcode (identifier)""nofollow""external text""https://ui.adsabs.harvard.edu/abs/2016PLoSO..1166718C""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1371%2Fjournal.pone.0166718""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5115794""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/27861583""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=PLOS+ONE&rft.atitle=T2DM+Self-Management+via+Smartphone+Applications%3A+A+Systematic+Review+and+Meta-Analysis.&rft.volume=11&rft.issue=11&rft.pages=e0166718&rft.date=2016&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5115794&rft_id=info%3Apmid%2F27861583&rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0166718&rft_id=info%3Abibcode%2F2016PLoSO..1166718C&rft.au=Cui%2C+M.&rft.au=Wu%2C+X.&rft.au=Mao%2C+J.&rft.au=Wang%2C+X.&rft.au=Nie%2C+M.&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5115794&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-:0-58""mw-cite-backlink""#cite_ref-:0_58-0""#cite_ref-:0_58-1""reference-text""CITEREFSafren,_S.A.Gonzalez,_J.S.Wexler,_D.J.Psaros,_C.2013""citation journal""nofollow""external text""http://care.diabetesjournals.org/content/early/2013/10/22/dc13-0816.short""A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdc13-0816""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC3931377""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/24170758""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=A+randomized+controlled+trial+of+cognitive+behavioral+therapy+for+adherence+and+depression+%28CBT-AD%29+in+patients+with+uncontrolled+type+2+diabetes.&rft.volume=37&rft.issue=3&rft.pages=625-33&rft.date=2013&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3931377&rft_id=info%3Apmid%2F24170758&rft_id=info%3Adoi%2F10.2337%2Fdc13-0816&rft.au=Safren%2C+S.A.&rft.au=Gonzalez%2C+J.S.&rft.au=Wexler%2C+D.J.&rft.au=Psaros%2C+C.&rft.au=Delahanty%2C+L.M.&rft.au=Blashill%2C+A.J.&rft.au=Margolina%2C+A.I.&rft.au=Cagliero%2C+E.&rft_id=http%3A%2F%2Fcare.diabetesjournals.org%2Fcontent%2Fearly%2F2013%2F10%2F22%2Fdc13-0816.short&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-:1-59""mw-cite-backlink""#cite_ref-:1_59-0""#cite_ref-:1_59-1""reference-text""CITEREFGonzalez,_J.S.Tanenbaum,_M.LCommissariat_P.V.2016""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5792162""Psychosocial factors in medication adherence and diabetes self-management: implications for research and practice""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1037%2Fa0040388""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC5792162""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/27690483""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=American+Psychologist&rft.atitle=Psychosocial+factors+in+medication+adherence+and+diabetes+self-management%3A+implications+for+research+and+practice&rft.volume=71&rft.issue=7&rft.pages=539-51&rft.date=2016&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5792162&rft_id=info%3Apmid%2F27690483&rft_id=info%3Adoi%2F10.1037%2Fa0040388&rft.au=Gonzalez%2C+J.S.&rft.au=Tanenbaum%2C+M.L&rft.au=Commissariat+P.V.&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5792162&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-60""mw-cite-backlink""#cite_ref-60""reference-text""CITEREFChew,_B._H.Vos,_R.Heijmans,_M.Metzendorf,_M._I.2015""citation journal""Psychological interventions for diabetes‐related distress in adults with type 2 diabetes mellitus""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1002%2F14651858.CD011469""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Cochrane+Database+of+Systematic+Reviews&rft.atitle=Psychological+interventions+for+diabetes%E2%80%90related+distress+in+adults+with+type+2+diabetes+mellitus&rft.volume=1&rft.date=2015&rft_id=info%3Adoi%2F10.1002%2F14651858.CD011469&rft.au=Chew%2C+B.+H.&rft.au=Vos%2C+R.&rft.au=Heijmans%2C+M.&rft.au=Metzendorf%2C+M.+I.&rft.au=Scholten%2C+R.+J.&rft.au=Rutten%2C+G.+E.&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-61""mw-cite-backlink""#cite_ref-61""reference-text""CITEREFLustmanAndersonFreedlandGroot2000""citation journal""nofollow""external text""http://care.diabetesjournals.org/content/23/7/934""Depression and poor glycemic control: a meta-analytic review of the literature""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.2337%2Fdiacare.23.7.934""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/0149-5992""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/10895843""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Depression+and+poor+glycemic+control%3A+a+meta-analytic+review+of+the+literature.&rft.volume=23&rft.issue=7&rft.pages=934-42&rft.date=2000-07-01&rft.issn=0149-5992&rft_id=info%3Apmid%2F10895843&rft_id=info%3Adoi%2F10.2337%2Fdiacare.23.7.934&rft.aulast=Lustman&rft.aufirst=P.+J.&rft.au=Anderson%2C+R.+J.&rft.au=Freedland%2C+K.+E.&rft.au=Groot%2C+M.+de&rft.au=Carney%2C+R.+M.&rft.au=Clouse%2C+R.+E.&rft_id=http%3A%2F%2Fcare.diabetesjournals.org%2Fcontent%2F23%2F7%2F934&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-62""mw-cite-backlink""#cite_ref-62""reference-text""nofollow""external text""https://doi.org/10.1016/j.psychres.2018.09.037""cite_note-63""mw-cite-backlink""#cite_ref-63""reference-text""CITEREFAliStonePetersDavies2006""citation journal""The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1111%2Fj.1464-5491.2006.01943.x""/wiki/ISSN_(identifier)""mw-redirect""ISSN (identifier)""nofollow""external text""//www.worldcat.org/issn/1464-5491""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17054590""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetic+Medicine&rft.atitle=The+prevalence+of+co-morbid+depression+in+adults+with+Type+2+diabetes%3A+a+systematic+review+and+meta-analysis&rft.volume=23&rft.issue=11&rft.pages=1165-73&rft.date=2006-11-01&rft.issn=1464-5491&rft_id=info%3Apmid%2F17054590&rft_id=info%3Adoi%2F10.1111%2Fj.1464-5491.2006.01943.x&rft.aulast=Ali&rft.aufirst=S.&rft.au=Stone%2C+M.+A.&rft.au=Peters%2C+J.+L.&rft.au=Davies%2C+M.+J.&rft.au=Khunti%2C+K.&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-64""mw-cite-backlink""#cite_ref-64""reference-text""CITEREFGonzalezPeyrotMcCarl2008""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2584202""Depression and diabetes treatment nonadherence: a meta-analysis""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdc08-1341""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC2584202""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/19033420""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=Depression+and+diabetes+treatment+nonadherence%3A+a+meta-analysis.&rft.volume=31&rft.issue=12&rft.pages=2398-403&rft.date=2008&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2584202&rft_id=info%3Apmid%2F19033420&rft_id=info%3Adoi%2F10.2337%2Fdc08-1341&rft.aulast=Gonzalez&rft.aufirst=JS&rft.au=Peyrot%2C+M&rft.au=McCarl%2C+LA&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2584202&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-Safren,_S._2014-65""mw-cite-backlink""#cite_ref-Safren,_S._2014_65-0""#cite_ref-Safren,_S._2014_65-1""reference-text""CITEREFSafrenGonzalezWexlerPsaros2014""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC3931377""A Randomized Controlled Trial of Cognitive Behavioral Therapy for Adherence and Depression (CBT-AD) in Patients With Uncontrolled Type 2 Diabetes""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2337%2Fdc13-0816""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC3931377""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/24170758""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Diabetes+Care&rft.atitle=A+Randomized+Controlled+Trial+of+Cognitive+Behavioral+Therapy+for+Adherence+and+Depression+%28CBT-AD%29+in+Patients+With+Uncontrolled+Type+2+Diabetes&rft.volume=37&rft.issue=3&rft.pages=625-33&rft.date=2014&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3931377&rft_id=info%3Apmid%2F24170758&rft_id=info%3Adoi%2F10.2337%2Fdc13-0816&rft.aulast=Safren&rft.aufirst=S&rft.au=Gonzalez%2C+J&rft.au=Wexler%2C+D&rft.au=Psaros%2C+C&rft.au=Delahanty%2C+L&rft.au=Blashill%2C+A&rft.au=Cagliero%2C+E&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3931377&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-66""mw-cite-backlink""#cite_ref-66""reference-text""nofollow""external text""http://www.isletmedical.com/pages/define_methods.htm""nofollow""external text""https://web.archive.org/web/20090115041618/http://www.isletmedical.com/pages/define_methods.htm""/wiki/Wayback_Machine""Wayback Machine""cite_note-pmid17426276-67""mw-cite-backlink""#cite_ref-pmid17426276_67-0""reference-text""CITEREFVoltarelliCouriStracieri2007""citation journal""Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.1001%2Fjama.297.14.1568""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17426276""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA&rft.atitle=Autologous+nonmyeloablative+hematopoietic+stem+cell+transplantation+in+newly+diagnosed+type+1+diabetes+mellitus&rft.volume=297&rft.issue=14&rft.pages=1568-76&rft.date=2007&rft_id=info%3Adoi%2F10.1001%2Fjama.297.14.1568&rft_id=info%3Apmid%2F17426276&rft.aulast=Voltarelli&rft.aufirst=JC&rft.au=Couri%2C+CE&rft.au=Stracieri%2C+AB&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-68""mw-cite-backlink""#cite_ref-68""reference-text""CITEREFCouriOliveiraStracieri2009""citation journal""C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.1001%2Fjama.2009.470""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/19366777""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=JAMA&rft.atitle=C-peptide+levels+and+insulin+independence+following+autologous+nonmyeloablative+hematopoietic+stem+cell+transplantation+in+newly+diagnosed+type+1+diabetes+mellitus&rft.volume=301&rft.issue=15&rft.pages=1573-79&rft.date=2009-04&rft_id=info%3Adoi%2F10.1001%2Fjama.2009.470&rft_id=info%3Apmid%2F19366777&rft.aulast=Couri&rft.aufirst=CE&rft.au=Oliveira%2C+MC&rft.au=Stracieri%2C+AB&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-69""mw-cite-backlink""#cite_ref-69""reference-text""nofollow""external text""http://www.niddk.nih.gov/fund/reports/gene_therapy_summ.htm""nofollow""external text""https://web.archive.org/web/20091029114009/http://www.niddk.nih.gov/fund/reports/gene_therapy_summ.htm""/wiki/Wayback_Machine""Wayback Machine""cite_note-70""mw-cite-backlink""#cite_ref-70""reference-text""nofollow""external text""http://www.liebertonline.com/doi/pdf/10.1089/dia.2005.7.549?cookieSet=1""cite_note-71""mw-cite-backlink""#cite_ref-71""reference-text""nofollow""external text""http://www.hopkinsbayview.org/healthcarenews06/060605diabetes.html""cite_note-72""mw-cite-backlink""#cite_ref-72""reference-text""nofollow""external text""http://www.engeneinc.com/""cite_note-Barnard_2007-73""mw-cite-backlink""#cite_ref-Barnard_2007_73-0""reference-text""CITEREFBarnard2007""citation book""cs1-lock-registration""Free registration required""nofollow""external text""https://archive.org/details/drnealbarnardspr00barn""13""cs1-lock-registration""Free registration required""nofollow""external text""https://archive.org/details/drnealbarnardspr00barn""/wiki/ISBN_(identifier)""mw-redirect""ISBN (identifier)""/wiki/Special:BookSources/978-1-59486-528-2""Special:BookSources/978-1-59486-528-2""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.atitle=13&rft.btitle=Dr.+Neal+Barnard%27s+Program+for+Reversing+Diabetes%3A+The+Scientifically+Proven+System+for+Reversing+Diabetes+Without+Drugs&rft.place=New+York%2C+NY&rft.pub=Rodale%2FHoltzbrinck+Publishers&rft.date=2007&rft.isbn=978-1-59486-528-2&rft.aulast=Barnard&rft.aufirst=Neal&rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fdrnealbarnardspr00barn&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-pmid19386029-74""mw-cite-backlink""#cite_ref-pmid19386029_74-0""reference-text""CITEREFBarnardKatcherJenkinsCohen2009""citation journal""nofollow""external text""https://semanticscholar.org/paper/a50182e6d1f25d7814f6577f53b18ef6d5d41791""Vegetarian and vegan diets in type 2 diabetes management""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1111%2Fj.1753-4887.2009.00198.x""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/19386029""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Nutrition+Reviews&rft.atitle=Vegetarian+and+vegan+diets+in+type+2+diabetes+management&rft.volume=67&rft.issue=5&rft.pages=255-63&rft.date=2009-05&rft_id=info%3Adoi%2F10.1111%2Fj.1753-4887.2009.00198.x&rft_id=info%3Apmid%2F19386029&rft.aulast=Barnard&rft.aufirst=ND&rft.au=Katcher%2C+HI&rft.au=Jenkins%2C+DJ&rft.au=Cohen%2C+J&rft.au=Turner-McGrievy%2C+G&rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2Fa50182e6d1f25d7814f6577f53b18ef6d5d41791&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-pmid18772488-75""mw-cite-backlink""#cite_ref-pmid18772488_75-0""reference-text""CITEREFTraishSaadGuay2009""citation journal""nofollow""external text""https://semanticscholar.org/paper/dd4815e820ab55ac12dc03f679c22b4b4a577e21""The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.2164%2Fjandrol.108.005751""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/18772488""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Journal+of+Andrology&rft.atitle=The+dark+side+of+testosterone+deficiency%3A+II.+Type+2+diabetes+and+insulin+resistance&rft.volume=30&rft.issue=1&rft.pages=23-32&rft.date=2009&rft_id=info%3Adoi%2F10.2164%2Fjandrol.108.005751&rft_id=info%3Apmid%2F18772488&rft.aulast=Traish&rft.aufirst=AM&rft.au=Saad%2C+F&rft.au=Guay%2C+A&rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2Fdd4815e820ab55ac12dc03f679c22b4b4a577e21&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-76""mw-cite-backlink""#cite_ref-76""reference-text""CITEREFZitzmann_M2009""citation journal""Testosterone deficiency, insulin resistance and the metabolic syndrome""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1038%2Fnrendo.2009.212""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/19859074""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Nature+Reviews+Endocrinology&rft.atitle=Testosterone+deficiency%2C+insulin+resistance+and+the+metabolic+syndrome&rft.volume=5&rft.issue=12&rft.pages=673-81&rft.date=2009-10&rft_id=info%3Adoi%2F10.1038%2Fnrendo.2009.212&rft_id=info%3Apmid%2F19859074&rft.au=Zitzmann+M&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-pmid12409659-77""mw-cite-backlink""#cite_ref-pmid12409659_77-0""reference-text""CITEREFRubinoGagner2002""citation journal""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC1422611""Potential of Surgery for Curing Type 2 Diabetes Mellitus""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1097%2F00000658-200211000-00003""/wiki/PMC_(identifier)""mw-redirect""PMC (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""//www.ncbi.nlm.nih.gov/pmc/articles/PMC1422611""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/12409659""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Annals+of+Surgery&rft.atitle=Potential+of+Surgery+for+Curing+Type+2+Diabetes+Mellitus&rft.volume=236&rft.issue=5&rft.pages=554-59&rft.date=2002-11&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1422611&rft_id=info%3Apmid%2F12409659&rft_id=info%3Adoi%2F10.1097%2F00000658-200211000-00003&rft.aulast=Rubino&rft.aufirst=F&rft.au=Gagner%2C+M&rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1422611&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-pmid17715409-78""mw-cite-backlink""#cite_ref-pmid17715409_78-0""reference-text""CITEREFAdamsGressSmith2007""citation journal""nofollow""external text""https://semanticscholar.org/paper/2908f0ef315574fb7fa5a7941c97091a7fddd012""Long-term mortality after gastric bypass surgery""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1056%2FNEJMoa066603""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17715409""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=The+New+England+Journal+of+Medicine&rft.atitle=Long-term+mortality+after+gastric+bypass+surgery&rft.volume=357&rft.issue=8&rft.pages=753-61&rft.date=2007-08&rft_id=info%3Adoi%2F10.1056%2FNEJMoa066603&rft_id=info%3Apmid%2F17715409&rft.aulast=Adams&rft.aufirst=TD&rft.au=Gress%2C+RE&rft.au=Smith%2C+SC&rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F2908f0ef315574fb7fa5a7941c97091a7fddd012&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-pmid17386401-79""mw-cite-backlink""#cite_ref-pmid17386401_79-0""reference-text""CITEREFCohenSchiavonPinheiroCorrea2007""citation journal""Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""nofollow""external text""https://doi.org/10.1016%2Fj.soard.2007.01.009""/wiki/PMID_(identifier)""mw-redirect""PMID (identifier)""nofollow""external text""//pubmed.ncbi.nlm.nih.gov/17386401""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=Surgery+for+Obesity+and+Related+Diseases&rft.atitle=Duodenal-jejunal+bypass+for+the+treatment+of+type+2+diabetes+in+patients+with+body+mass+index+of+22%E2%80%9334+kg%2Fm2%3A+a+report+of+2+cases&rft.volume=3&rft.issue=2&rft.pages=195-97&rft.date=2007&rft_id=info%3Adoi%2F10.1016%2Fj.soard.2007.01.009&rft_id=info%3Apmid%2F17386401&rft.aulast=Cohen&rft.aufirst=RV&rft.au=Schiavon%2C+CA&rft.au=Pinheiro%2C+JS&rft.au=Correa%2C+JL&rft.au=Rubino%2C+F&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-NS-80""mw-cite-backlink""#cite_ref-NS_80-0""reference-text""CITEREFVasonconcelos2007""citation journal""nofollow""external text""https://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html""Could type 2 diabetes be reversed using surgery?""/wiki/New_Scientist""New Scientist""reference-accessdate""nowrap""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=New+Scientist&rft.atitle=Could+type+2+diabetes+be+reversed+using+surgery%3F&rft.issue=2619&rft.pages=11-13&rft.date=2007-09-01&rft.aulast=Vasonconcelos&rft.aufirst=Alberto&rft_id=https%3A%2F%2Fwww.newscientist.com%2Fchannel%2Fhealth%2Fmg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""cite_note-81""mw-cite-backlink""#cite_ref-81""reference-text""CITEREFElkholyLardhi2015""citation journal""Do we need to test for maturity onset diabetes of the young among newly diagnosed diabetics in Saudi Arabia?""/wiki/Doi_(identifier)""mw-redirect""Doi (identifier)""cs1-lock-free""Freely accessible""nofollow""external text""https://doi.org/10.1016%2Fj.ijdm.2011.01.006""ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.jtitle=International+Journal+of+Diabetes+Mellitus&rft.atitle=Do+we+need+to+test+for+maturity+onset+diabetes+of+the+young+among+newly+diagnosed+diabetics+in+Saudi+Arabia%3F&rft.volume=3&rft.issue=1&rft.pages=51-56&rft.date=2015-05-01&rft_id=info%3Adoi%2F10.1016%2Fj.ijdm.2011.01.006&rft.aulast=Elkholy&rft.aufirst=Suzanne&rft.au=Lardhi%2C+Amer+A.&rfr_id=info%3Asid%2Fen.wikipedia.org%3ADiabetes+management""Z3988""mw-deduplicated-inline-style""mw-data:TemplateStyles:r951705291""mw-headline""External_links""mw-editsection""mw-editsection-bracket""/w/index.php?title=Diabetes_management&action=edit&section=32""Edit section: External links""mw-editsection-bracket""nofollow""external text""http://diabetes.acponline.org/""nofollow""external text""http://www.diabetes.org""nofollow""external text""http://diabetes.niddk.nih.gov/dm/pubs/complications_control/index.htm""National Diabetes Information Clearinghouse""navigation""navbox""Diabetes_(E10–E14,_250)""padding:3px""nowraplinks mw-collapsible autocollapse navbox-inner""border-spacing:0;background:transparent;color:inherit""col""navbox-title""2""plainlinks hlist navbar mini""nv-view""/wiki/Template:Diabetes""Template:Diabetes""View this template"";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;""nv-talk""/wiki/Template_talk:Diabetes""Template talk:Diabetes""Discuss this template"";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;""nv-edit""external text""https://en.wikipedia.org/w/index.php?title=Template:Diabetes&action=edit""Edit this template"";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;""Diabetes_(E10–E14,_250)""font-size:114%;margin:0 4em""/wiki/Diabetes""Diabetes""/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#E00–E35_–_Endocrine_diseases""ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases""/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Disorders_of_thyroid_gland_(240–246)""List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders""row""navbox-group""width:1%""navbox-list navbox-odd hlist""text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px""padding:0em 0.25em""/wiki/Type_1_diabetes""Type 1 diabetes""/wiki/Type_2_diabetes""Type 2 diabetes""/wiki/Latent_autoimmune_diabetes_in_adults""Latent autoimmune diabetes in adults""/wiki/Gestational_diabetes""Gestational diabetes""/wiki/Diabetes_and_pregnancy""Diabetes and pregnancy""/wiki/Prediabetes""Prediabetes""/wiki/Impaired_fasting_glucose""Impaired fasting glucose""/wiki/Impaired_glucose_tolerance""mw-redirect""Impaired glucose tolerance""/wiki/Insulin_resistance""Insulin resistance""/wiki/Ketosis-prone_diabetes""Ketosis-prone diabetes""/wiki/Maturity_onset_diabetes_of_the_young""Maturity onset diabetes of the young""/wiki/Neonatal_diabetes""Neonatal diabetes""/wiki/Transient_neonatal_diabetes""Transient neonatal diabetes""/wiki/Permanent_neonatal_diabetes""Permanent neonatal diabetes""/wiki/Type_3c_(pancreatogenic)_diabetes""Type 3c (pancreatogenic) diabetes""/wiki/Type_3_diabetes""Type 3 diabetes""row""navbox-group""width:1%""/wiki/Blood_test""Blood test""navbox-list navbox-even hlist""text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px""padding:0em 0.25em""/wiki/Blood_sugar_level""Blood sugar level""/wiki/Glycated_hemoglobin""Glycated hemoglobin""/wiki/Glucose_tolerance_test""Glucose tolerance test""/wiki/Postprandial_glucose_test""Postprandial glucose test""/wiki/Fructosamine""Fructosamine""/wiki/Glucose_test""Glucose test""/wiki/C-peptide""C-peptide""/wiki/Noninvasive_glucose_monitor""Noninvasive glucose monitor""/wiki/Insulin_tolerance_test""Insulin tolerance test""row""navbox-group""width:1%""mw-selflink selflink""navbox-list navbox-odd hlist""text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px""padding:0em 0.25em""/wiki/Diabetic_diet""Diabetic diet""/wiki/Anti-diabetic_medication""Anti-diabetic medication""/wiki/Insulin_(medication)""Insulin (medication)""/wiki/Intensive_insulin_therapy""Intensive insulin therapy""/wiki/Conventional_insulin_therapy""Conventional insulin therapy""/wiki/Pulsatile_insulin""Pulsatile insulin""/wiki/Embryonic_stem_cell""Embryonic stem cell""/wiki/Artificial_pancreas""Artificial pancreas""/wiki/Gastric_bypass_surgery#Results_and_health_benefits_of_gastric_bypass""Gastric bypass surgery""row""navbox-group""width:1%""/wiki/Complications_of_diabetes""Complications of diabetes""navbox-list navbox-even hlist""text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px""padding:0em 0.25em""/wiki/Diabetic_coma""Diabetic coma""/wiki/Diabetic_hypoglycemia""Diabetic hypoglycemia""/wiki/Diabetic_ketoacidosis""Diabetic ketoacidosis""/wiki/Hyperosmolar_hyperglycemic_state""Hyperosmolar hyperglycemic state""/wiki/Diabetic_foot""Diabetic foot""/wiki/Diabetic_foot_ulcer""Diabetic foot ulcer""/wiki/Neuropathic_arthropathy""Neuropathic arthropathy""/wiki/Diabetic_angiopathy""Diabetic angiopathy""/wiki/Diabetic_myonecrosis""Diabetic myonecrosis""/wiki/Diabetic_nephropathy""Diabetic nephropathy""/wiki/Diabetic_neuropathy""Diabetic neuropathy""/wiki/Diabetic_retinopathy""Diabetic retinopathy""/wiki/Diabetic_cardiomyopathy""Diabetic cardiomyopathy""/wiki/Diabetic_dermadrome""Diabetic dermadrome""/wiki/Diabetic_dermopathy""Diabetic dermopathy""/wiki/Diabetic_bulla""Diabetic bulla""/wiki/Diabetic_cheiroarthropathy""Diabetic cheiroarthropathy""/wiki/Diabetic_foot_ulcer""Diabetic foot ulcer""/wiki/Hyperglycemia""Hyperglycemia""/wiki/Hypoglycemia""Hypoglycemia""row""navbox-group""width:1%""navbox-list navbox-odd hlist""text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px""padding:0em 0.25em""/wiki/Glossary_of_diabetes""Glossary of diabetes""/wiki/History_of_diabetes""History of diabetes""/wiki/List_of_people_with_type_1_diabetes""List of people with type 1 diabetes""//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1""""""1""1""border: none; position: absolute;""printfooter""https://en.wikipedia.org/w/index.php?title=Diabetes_management&oldid=956174810""catlinks""catlinks""interface""mw-normal-catlinks""mw-normal-catlinks""/wiki/Help:Category""Help:Category""/wiki/Category:Diabetes""Category:Diabetes""mw-hidden-catlinks""mw-hidden-catlinks mw-hidden-cats-hidden""/wiki/Category:Webarchive_template_wayback_links""Category:Webarchive template wayback links""/wiki/Category:Articles_with_short_description""Category:Articles with short description""/wiki/Category:All_articles_with_unsourced_statements""Category:All articles with unsourced statements""/wiki/Category:Articles_with_unsourced_statements_from_November_2011""Category:Articles with unsourced statements from November 2011""/wiki/Category:All_articles_with_vague_or_ambiguous_time""Category:All articles with vague or ambiguous time""/wiki/Category:Vague_or_ambiguous_time_from_April_2011""Category:Vague or ambiguous time from April 2011""/wiki/Category:Articles_with_unsourced_statements_from_February_2020""Category:Articles with unsourced statements from February 2020""visualClear""read-more-container""mw-navigation""mw-head""p-personal""navigation""""p-personal-label""p-personal-label""pt-anonuserpage""pt-anontalk""/wiki/Special:MyTalk""Discussion about edits from this IP address [n]""n""pt-anoncontribs""/wiki/Special:MyContributions""A list of edits made from this IP address [y]""y""pt-createaccount""/w/index.php?title=Special:CreateAccount&returnto=Diabetes+management""You are encouraged to create an account and log in; however, it is not mandatory""pt-login""/w/index.php?title=Special:UserLogin&returnto=Diabetes+management""You're encouraged to log in; however, it's not mandatory. [o]""o""left-navigation""p-namespaces""navigation""vectorTabs""p-namespaces-label""p-namespaces-label""ca-nstab-main""selected""/wiki/Diabetes_management""View the content page [c]""c""ca-talk""/wiki/Talk:Diabetes_management""discussion""Discuss improvements to the content page [t]""t""p-variants""navigation""emptyPortlet vectorMenu""p-variants-label""checkbox""vectorMenuCheckbox""p-variants-label""p-variants-label""menu""right-navigation""p-views""navigation""vectorTabs""p-views-label""p-views-label""ca-view""collapsible selected""/wiki/Diabetes_management""ca-edit""collapsible""/w/index.php?title=Diabetes_management&action=edit""Edit this page [e]""e""ca-history""collapsible""/w/index.php?title=Diabetes_management&action=history""Past revisions of this page [h]""h""p-cactions""navigation""emptyPortlet vectorMenu""p-cactions-label""checkbox""vectorMenuCheckbox""p-cactions-label""p-cactions-label""menu""p-search""search""searchInput""/w/index.php""searchform""simpleSearch""search""search""Search Wikipedia""Search Wikipedia [f]""f""searchInput""hidden""Special:Search""title""submit""fulltext""Search""Search Wikipedia for this text""mw-searchButton""searchButton mw-fallbackSearchButton""submit""go""Go""Go to a page with this exact name if it exists""searchButton""searchButton""mw-panel""p-logo""banner""Visit the main page""mw-wiki-logo""/wiki/Main_Page""portal portal-first""navigation""p-navigation""p-navigation-label""p-navigation-label""body""n-mainpage-description""/wiki/Main_Page""Visit the main page [z]""z""n-contents""/wiki/Wikipedia:Contents""Guides to browsing Wikipedia""n-featuredcontent""/wiki/Wikipedia:Featured_content""Featured content – the best of Wikipedia""n-currentevents""/wiki/Portal:Current_events""Find background information on current events""n-randompage""/wiki/Special:Random""Load a random article [x]""x""n-sitesupport""https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en""Support us""n-shoplink""//shop.wikimedia.org""Visit the Wikipedia store""portal""navigation""p-interaction""p-interaction-label""p-interaction-label""body""n-help""/wiki/Help:Contents""Guidance on how to use and edit Wikipedia""n-aboutsite""/wiki/Wikipedia:About""Find out about Wikipedia""n-portal""/wiki/Wikipedia:Community_portal""About the project, what you can do, where to find things""n-recentchanges""/wiki/Special:RecentChanges""A list of recent changes in the wiki [r]""r""n-contactpage""//en.wikipedia.org/wiki/Wikipedia:Contact_us""How to contact Wikipedia""portal""navigation""p-tb""p-tb-label""p-tb-label""body""t-whatlinkshere""/wiki/Special:WhatLinksHere/Diabetes_management""List of all English Wikipedia pages containing links to this page [j]""j""t-recentchangeslinked""/wiki/Special:RecentChangesLinked/Diabetes_management""nofollow""Recent changes in pages linked from this page [k]""k""t-upload""/wiki/Wikipedia:File_Upload_Wizard""Upload files [u]""u""t-specialpages""/wiki/Special:SpecialPages""A list of all special pages [q]""q""t-permalink""/w/index.php?title=Diabetes_management&oldid=956174810""Permanent link to this revision of the page""t-info""/w/index.php?title=Diabetes_management&action=info""More information about this page""t-wikibase""https://www.wikidata.org/wiki/Special:EntityPage/Q2089287""Link to connected data repository item [g]""g""t-cite""/w/index.php?title=Special:CiteThisPage&page=Diabetes_management&id=956174810&wpFormIdentifier=titleform""Information on how to cite this page""portal""navigation""p-coll-print_export""p-coll-print_export-label""p-coll-print_export-label""body""coll-download-as-rl""/w/index.php?title=Special:ElectronPdf&page=Diabetes+management&action=show-download-screen""t-print""/w/index.php?title=Diabetes_management&printable=yes""Printable version of this page [p]""p""portal""navigation""p-lang""p-lang-label""p-lang-label""body""interlanguage-link interwiki-ar""https://ar.wikipedia.org/wiki/%D8%B6%D8%A8%D8%B7_%D8%A7%D9%84%D8%B3%D9%83%D8%B1%D9%8A""ضبط السكري – Arabic""ar""ar""interlanguage-link-target""interlanguage-link interwiki-fa""https://fa.wikipedia.org/wiki/%D9%85%D8%AF%DB%8C%D8%B1%DB%8C%D8%AA_%D8%AF%DB%8C%D8%A7%D8%A8%D8%AA""مدیریت دیابت – Persian""fa""fa""interlanguage-link-target""interlanguage-link interwiki-ko""https://ko.wikipedia.org/wiki/%EB%8B%B9%EB%87%A8%EB%B3%91%EC%9D%98_%EA%B4%80%EB%A6%AC""당뇨병의 관리 – Korean""ko""ko""interlanguage-link-target""interlanguage-link interwiki-ja""https://ja.wikipedia.org/wiki/%E7%B3%96%E5%B0%BF%E7%97%85%E3%81%AE%E6%B2%BB%E7%99%82""糖尿病の治療 – Japanese""ja""ja""interlanguage-link-target""interlanguage-link interwiki-pt""https://pt.wikipedia.org/wiki/Tratamento_da_diabetes_mellitus""Tratamento da diabetes mellitus – Portuguese""pt""pt""interlanguage-link-target""interlanguage-link interwiki-ru""https://ru.wikipedia.org/wiki/%D0%A1%D0%B0%D0%BC%D0%BE%D0%BA%D0%BE%D0%BD%D1%82%D1%80%D0%BE%D0%BB%D1%8C_%D0%BF%D1%80%D0%B8_%D1%81%D0%B0%D1%85%D0%B0%D1%80%D0%BD%D0%BE%D0%BC_%D0%B4%D0%B8%D0%B0%D0%B1%D0%B5%D1%82%D0%B5""Самоконтроль при сахарном диабете – Russian""ru""ru""interlanguage-link-target""interlanguage-link interwiki-si""https://si.wikipedia.org/wiki/Diabetes_(Treatment_and_management)""Diabetes (Treatment and management) – Sinhala""si""si""interlanguage-link-target""after-portlet after-portlet-lang""wb-langlinks-edit wb-langlinks-link""https://www.wikidata.org/wiki/Special:EntityPage/Q2089287#sitelinks-wikipedia""Edit interlanguage links""wbc-editpage""footer""mw-footer""contentinfo""footer-info""footer-info-lastmod""anonymous-show""footer-info-copyright""license""//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License""license""//creativecommons.org/licenses/by-sa/3.0/""display:none;""//foundation.wikimedia.org/wiki/Terms_of_Use""//foundation.wikimedia.org/wiki/Privacy_policy""//www.wikimediafoundation.org/""footer-places""footer-places-privacy""https://foundation.wikimedia.org/wiki/Privacy_policy""extiw""wmf:Privacy policy""footer-places-about""/wiki/Wikipedia:About""Wikipedia:About""footer-places-disclaimer""/wiki/Wikipedia:General_disclaimer""Wikipedia:General disclaimer""footer-places-contact""//en.wikipedia.org/wiki/Wikipedia:Contact_us""footer-places-developers""https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute""footer-places-statslink""https://stats.wikimedia.org/#/en.wikipedia.org""footer-places-cookiestatement""https://foundation.wikimedia.org/wiki/Cookie_statement""footer-places-mobileview""//en.m.wikipedia.org/w/index.php?title=Diabetes_management&mobileaction=toggle_view_mobile""noprint stopMobileRedirectToggle""footer-icons""noprint""footer-copyrightico""https://wikimediafoundation.org/""/static/images/wikimedia-button.png""/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x""88""31""Wikimedia Foundation""footer-poweredbyico""https://www.mediawiki.org/""/static/images/poweredby_mediawiki_88x31.png""Powered by MediaWiki""/static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x""88""31""clear: both;">